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 ABSTRACT  
 
 Glycosaminoglycans are carboyhydrate side chains of proteoglycans that have a 
myriad of biological functions.  In the brain, these molecules are implicated in everything 
from development to plasticity to disease.  Two of the main types of glycosaminoglycans 
(GAGs), heparan sulfate and chondroitin sulfate, have been implicated in both plasticity 
and learning; however, the exact role they play has remained unclear.  One of the more 
interesting sensorimotor systems in the brain involves the learning and production of 
vocalizations.  The goal of this work was to investigate the role GAGs play in two 
different aspects of this complex behavior, the neural control of vocal ontogeny and 
superfast muscle involvement in song production of zebra finch.   
In order to fully understand the role GAGs play in complex biological behaviors, 
such as vocalizations, it is imperative that the proper tools be synthesized, characterized, 
and produced for the study of these carbohydrates.  Enzymes, specifically sulfated 
polymers and oligosaccharides, and small molecules provide unique opportunities to 
examine the role of GAGs.  The use of enzymes in the song-specific nucleus, HVC, 
allowed the validation of the functionality of these enzymes in the model system of 
interest.  Changes in stereotyped song were observed showing that GAG modulation 
could lead to alteration of a learned behavior.    
After this confirmation that GAGs were present and involved in song, small 
molecules called xylosides were used to examine the role of chondroitin sulfate 
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biosynthesis during vocal ontogeny.  Infusion of xyloside into RA (robust nucleus of the 
arcopallium), a nucleus important for vocal ontogeny, led to a change in the development 
of song.  This implies that regulated biosynthesis of chondroitin sulfate during the critical 
period for vocal ontogeny is important.  
 Lastly, the role of superfast syringeal muscles in song production was examined.  
Heparan sulfate degradation in these muscles alters the ability of the syrinx to modulate 
airflow.  This change in muscle kinetics was correlated with significant, but temporary, 
differences in acoustic structure and frequency modulation while long-term differences 
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CHAPTER 1  
INTRODUCTION  
 
1.1 Overview of glycosaminoglycans 
1.1.1 Structures of glycosaminoglycans 
Proteoglycans (PGs) are macromolecules consisting of a core protein and multiple 
glycosaminoglycan (GAG) side chains.  PGs can be further defined into families by their 
core protein sequence, the type of protein, and the number/type of GAG chains that extend 
from the core protein.  There are four main types of PG: heparan sulfate (HS), chondroitin 
sulfate (CS), dermatan sulfate (DS), and keratan sulfate (KS).  PGs are attached to cell 
membranes through either transmembrane domains (i.e., syndecan) or 
glycosylphosphatidylinositol (GPI) anchored (i.e., glypican). Alternatively, PGs can be 
secreted into the extracellular matrix (ECM) such as the PGs biglycan, decorin, aggrecan, 
and perlecan.  Most PGs have two or more GAG side chains; however, some PGs can have 
hundreds.1,2  Examples of the different structures of PG can be seen in Figure 1.1. 
Extending from specific serine residues on the core protein, GAGs are linear 
polysaccharides with varying sulfation patterns.  Each chain consists of repeating 
disaccharide units of hexosamine, either glucosamine or galactosamine, and hexuronic 
acid, either glucuronic or iduronic.  This diversity allows the classification of GAG chains 
into four major types.  HS chains have repeating disaccharide units of N-acetyl glucose-
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amine (GlcNAc) and either glucuronic acid (GlcA) or iduronic acid (IdoA).  CS chains 
have repeating units of GlcA and N-acetyl galactosamine (GalNAc).  DS chains have 
repeating units of GalNAc and IdoA/GlcA and KS chains have repeating units of  galactose 
(Gal) and GlcNAc.  Chains of different type can be found on the same core protein. For 
example, aggrecan has both KS and CS, but it is considered a chondroitin sulfate 
proteoglycan (CSPG) because it has a larger number of CS chains than KS chains.  The 
disaccharide units of each type of GAG chain are shown in Figure 1.2.  It is the repeating 
units that provide the heterogeneity of the GAG chains themselves.  Within each major 
type, the disaccharide units can vary in glycosidic linkage, type of sugar, and number of 
the sulfate groups.  This provides additional heterogeneity and gives GAGs a unique, 
nontemplated assembly that allows for multiple functions of a single GAG chain.  The two 
of the major types of GAG that dominate glycobiology research are HS and CS.  It is these 
molecules that are the focus of this work. 
 
 
1.1.2 Biosynthesis of glycosaminoglycans  
 
Biosynthesis of GAGs is a nontemplated process that requires the use of many 
different enzymes, sugar activators, and transporters.  It has been shown that the expression 
of these enzymes and transporters is tightly controlled developmentally and occurs in a 
tissue-specific manner.  Temporal and spatial control creates a diverse set of fine structures 
and can result in PGs in two separate tissues with the same core protein but different GAG 
chain structure3-6. 
Figure 1.3 depicts HS and CS biosynthesis.  Biosynthesis begins with the 
xylosylation step.  During this step, Xylosyltransferase transfers a xylose (Xyl) residue 
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from a UDP-xylose to a specific serine residue present within the core protein.  This begins 
the formation of the linkage region found in GAGs.  After the addition of the xylose, two 
galactosyltransferases (GALT-I, GALT-II) add two Gal residues followed by the addition 
of GlcA by glucuron transfylerase-I (GLCAT-I) to complete assembly of the linkage 
region.  This linkage region can be further modified through phosphorylation and/or 
sulfation of Xyl or Gal residues3. The addition of a 1,4 linked GlcNAc as a fifth residue 
dictates the formation of HS, whereas the addition of a 1,4 linked GalNAc at the fifth  
residue directs the synthesis of CS.  The mechanism that regulates the addition of the fifth 
residue is largely unknown. 
HS/CS chain biosynthesis consists of two mains steps:  extension and modification.  
For HS, following the addition of the GlcNAc after the linkage region, exostoses, EXT1 
and EXT2, add repeating disaccharide units of GlcA and GlcNAc to extend the chain.  
While extension occurs, other enzymes follow behind the exostoses and modify the GAG 
chain3.  This is believed to take place in the Golgi apparatus in specialized compartments 
which house specific enzyme complexes called GAGOSOMES.   
The gateway modification appears to be the N-deacylation and N-sulfation of 
GlcNAc residues by the N-deacetyl-N-sulfotransferase (NDST) enzyme.  N-sulfation is 
required or preferred for subsequent modifications.  Immediately after N-sulfation, C5-
epimerase (C5-Epi) can convert GlcA to IdoA.  A variety of O-sulfotransferase (OST) 
enzymes can add sulfate groups to specific locations on the disaccharide unit.  Sulfate 
groups can be added to C6 (6-OST) and C3 (3-OST) of glucosamine residues and C2 (2-
OST) of IdoA predominantly and GlcA rarely3-6. These modifications are the result of the 
transfer of a sulfate group from 3’-Phosphoadenosine-5’-phosphosulfate (PAPS) to the HS 
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chain by the OST enzymes.  PAPS is formed in animals by a single enzyme that has both 
a sulfurylase and kinase activity.  However, in plants and fungi, PAPS synthesis is carried 
out by two separate enzymes.  Figure 1.4 shows the cycle of PAPS production and use, 
requiring separate and fused enzymes7.  Previous studies indicate that the concentration of 
PAPS partially controls the level of GAG sulfation7.   
The OST enzymes are developmentally regulated as well as tightly controlled in a 
spatio-temporal manner. The OST biosynthetic enzymes have multiple isoforms.  For 
example, four NDST, one C5-epimerase, one 2-OST, seven 3-OST, and three 6-OST 
isoforms have been found in humans and other organisms.  Specificity of enzyme isoforms 
in regard to sulfation and polymer size have been studied in vitro8,9.  Though it is unclear 
if this specificity is maintained inside the cell or if specificity is cell type dependent, 
controlled expression of enzymes leads to the creation of three domains in HS:  highly 
sulfated domains (NS domains), nonsulfated domains (NA domains), and partially sulfated 
domains (NA/NS domains).  These domains increase the complex architecture of the GAG 
chain.  It is believed that the presence of GAGOSOMEs, containing specific composition 
and location of HS biosynthetic enzymes, gives rise to these different domains as well as 
the influence of additional enzymes outside the cell such as sulfatase (SULF) which can 
remove 6-O-sulfate10.  The diversity of structure provided by modifications in HS results 
in a wide array of biological function1,6.  Understanding the structure-function relationship 
of HS and other molecules remains one of the most intriguing questions in the field of 
glycobiology.   
CS chains are synthesized in a similar fashion.  After formation of the linkage 
region, a GalNAc is added as the fifth residue.  Chondroitin synthase enzymes then extend 
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the chain through the addition of repeating disaccharide units of GlcA and GalNAc.  
Modification of the chain by sulfation can occur at the C4 or C6 of the GalNAc residue as 
extension occurs. This sulfation is performed by the CS-specific sulfotransferases: 
chondroitin-4-sulfotransferase and chondroitin-6-sulfotransferase.  Other than DS, one 
other CS has IdoA.  Sulfation allows the classification of CS into specific classes:  CS-A, 
CS-C, CS-D, and CS-E. DS chains were commonly referred to as CS-B, but are now 
primarily labeled as DS.  The major difference in DS/CS-E versus other CS classes is the 
prevalent epimeriazation of GlcA to IdoA in the disaccharide units and the presence of a 
sulfate group at the C2 position of the IdoA11. 
The modifications are believed to occur in specific compartments within the Golgi 
apparatus containing the specific enzymes complexes called GAGOSOMES9.  There is 
also a large degree of heterogeneity and structural diversity in CS.  The structure-function 
relationship of CS and binding ligands, as well as how the different classes can influence 
distinct biological functions, are the subject of much current research12,13. 
 
1.1.3 Glycosaminoglycans in learning and memory 
 
A variety of proteoglycans has been found to exist in both the developing and 
mature central nervous system (CNS).  GAGs in the CNS are found to be primarily HS or 
CS and constitute part of the ECM or are located at the cell surface.  These GAGs have 
many different functions in the CNS and multiple forms of the same core protein exist 
within the tissue.  For example, there are four known mammalian syndecans, which are 
structurally similar but have distinct cellular distributions14,15. 
HS plays a role in many neuronal processes and in neuronal development.  During 
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development, HS is known to be involved in axon guidance, synaptogenesis, synaptic 
plasticity, patterning, and cell proliferation.  Another major role is the interaction of HS 
and external ligands not only in the developing but also in the mature CNS14.  These 
external ligands include growth factors, matrix ligands, and cell surface and cell adhesion 
molecules.  Interactions of HSPGs with growth factors active in the CNS include:  neural 
cell adhesion molecule (NCAM), fibroblast growth factor (FGF), Wnt, transforming 
growth factor-β (TGF-β), and heparin-binding growth factors10,16-22.  Interaction of HS with 
many of these external ligands is essential for the formation of many different neural 
structures and networks13,23,24. 
CS is shown to affect axon growth, cell plasticity, and cell migration in the CNS.  
CS binds ligands such as NCAM, tenascin-C, and tenascin-R.  The core protein from 
phosphacan, a CSPG, has been found to bind FGF-2.  However, the primary function of 
CSPGs in neural development is to serve as barrier molecules to regulate growth and 
neuronal plasticity.  CS can act as a repulsive cue during neuronal cell migration, axon 
growth, or elongation and after CNS lesion.  Neurocan and phosphacan are present in large 
quantities during neuronal development, with neurocan being synthesized by neurons and 
phosphacan being made by astrocytes25.  After development, brevican, the most 
predominant form of CS, is produced by astrocytes and serves as a component of the 
perineuronal network.  The presence of these CSPGs is one of the main barriers to axon re-
growth following injury.  Digestion of these GAG chains with a CS degrading enzyme, 
chondroitinase ABC, results in enhanced axon elongation26-28. 
Recent studies have begun to show a link between GAGs and the neurological 
processes involved in learning and memory.  The interaction of GAGs with growth factors 
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as well as their involvement in synaptic plasticity and axon growth makes them viable 
candidates for affecting learning and memory.  The most commonly studied form of 
learning and memory is the hippocampus-dependent spatial learning.  One measure for this 
is hippocampal synaptic plasticity, which can be studied as changes in long-term 
potentiation (LTP).  LTP also serves as a measure for activity-dependent plasticity in the 
hippocampus.  Spatial learning and memory are often, but not always, correlated with LTP 
in the hippocampus29.    
HS can act as a modulator of synaptic plasticity in the hippocampus.  Synaptic 
modification can regulate the plasticity of learning and memory in the brain.  This can be 
seen in syndecan deficient mice.  Syndecan-3 deficient mice show enhanced LTP in the 
CA1 region of the hippocampus.  This occurs because syndecan-3 in wildtype (WT) mice 
responds to a ligand that is a heparin-binding growth-association molecule.  This molecule 
inhibits LTP in the CA1 region of the hippocampus29.  Syndecan-2 plays a role in dendritic 
spine development in hippocampal neurons.  Spine formation and changes in spine 
morphology are known to occur in LTP, sensory deprivation, some forms of mental 
retardation, and autism30-33.  Maturation of dendritic spines in the hippocampus is important 
for learning and memory.  Syndecan-2 is localized to dendritic spines and appears during 
the time frame for development and maturation of the spines.  When syndecan-2 expression 
is induced in hippocampal dendrites in young neurons, there are morphological changes in 
the protrusions that would be dendritic spines.  These changes were similar to those found 
in mature neurons34.  Changes in sulfation patterns of HS can also lead to alterations in 
synaptic plasticity in the hippocampus.  Mice deficient in SULF1 or SULF2 have aberrant 
neurite outgrowth in hippocampal and cerebellar neurons.  These sulfatases are responsible 
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for removing specific 6-O-sulfate groups from HS.  The removal of these sulfates 
modulates signaling pathways involved in development and homeostasis.  A loss of the 
SULF1 enzyme results in a reduced hippocampal spine density and impaired LTP in the 
CA1 of the hippocampus35. 
 CS can also affect synaptic plasticity in the hippocampus.  Removal of CS from 
the hippocampus can result in altered synaptic plasticity as seen by changes in LTP.  When 
hippocampal slices were pretreated with chondroitinase ABC to remove all CS, subsequent 
treatment with chondroitinase ABC did not affect single pulse excitatory synaptic 
transmission or short-term plasticity. However, LTP in CA1 of the hippocampus was 
reduced.  The loss of the tenascan-R ligand results in increased single pulse transmission 
and reduced short-term plasticity.  LTP is reduced in a manner similar to enzyme treated 
slices36.  Neurocan deficient mice show no change in early phase LTP but show impairment 
in late-phase LTP37 and mice deficient in brevican, which is found in the adult brain, show 
a lack of LTP38.  The differences in effects of neurocan, which is prevalent earlier in 
development, and brevican, which is more prevalent in the adult nervous system, show that 
the different CSPGs are involved in the different stages of LTP39. 
While these changes in hippocampal synaptic plasticity lay the ground work for the 
argument for the involvement of GAGs in learning and memory, simple changes in LTP 
are not sufficient as evidence for changes in learning.  In order to better examine the 
relationship between GAGs and learning, it is necessary to examine behavioral changes 
that may result from alterations in GAGs in the CNS.  A number of learning and memory 
task assays, such as operant chambers, radial arm mazes, water mazes, and delayed match 
to sample, have been used to examine the relationship between GAGs and learning and 
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memory.  Both HS and CS can affect learning and memory as seen by altered behavior. 
Alteration of LTP in the hippocampus due to HS can also affect the behavioral 
response of the animals.  In syndecan-3 deficient mice, deficits in hippocampus-dependent 
forms of learning and memory were observed.  Syndecan-3 deficient mice were impaired 
in the water maze test and showed reduced context-dependent freezing in response to fear 
conditioning29.  More evidence for the role of HSPGs in learning and memory is found by 
the deficits that are seen in mice that are deficient in SULF1 and SULF2.  These SULF-
deficient mice showed deficits in neuromotor test performance and learning performance.  
SULF2-deficient mice show a reduction in grip strength and a deficiency in the water maze 
task as seen by slower escape latency.  SULF1-deficient mice showed a reduction in 
nocturnal exploration and slower rate of acquisition during the water maze task35.   
HS can also be linked to enhanced learning in rats.  The injection of heparin, a 
complex polysaccharide closely related to heparan sulfate, into the ventral pallidum after 
learning had occurred facilitated both the short-term and long-term retention of a 
conditioned avoidance response task.  These effects followed an inverted u-shaped curve 
and were only present if heparin was administered immediately after the task.  A delay of 
the injection by 5 h no longer produced the effect.  The mechanism behind this improved 
performance is still unknown but could be related to growth factor signaling or the 
influence of extra-synaptic communication through heparin-binding molecules40.   
The effects of CS on behavioral aspects of learning and memory have been 
examined in mutants.  While some mutants show alterations in LTP, some have no apparent 
effects on learning and memory.  Brevican-null mice, who lack LTP, show no obvious 
deficits in learning and memory in a behavioral task38.  Additionally, learning can be 
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facilitated by CS.  Biglycan and CS-C, injected into the ventral pallidum, facilitate learning.  
Injections of biglycan immediately after training influenced the performance and facilitated 
inhibitory avoidance learning, while delayed injections after training did not affect 
performance, suggesting that the CSPG most likely influences memory storage rather than 
retrieval.  Biglycan also shows facilitation of habituation of exploratory learning.  
Injections of CS C also improved habituation learning41.  CS is also known to be involved 
in fear learning.  CS makes up a large portion of the perineuronal nets (PNNs) around the 
amygdala and are thought to protect fear memory formation.  Destruction of the PNN using 
chondroitinase ABC makes subsequently acquired fear memories susceptible to forgetting, 
and subjects showed no spontaneous recovery42.  These examples show that the effect of 
CS on learning and memory is CS class and learning/memory task dependent.   
Evidence for the involvement of GAGs in learning and memory is slowly 
accumulating.  This evidence provides a strong foundation for future research that focuses 
on GAGs in various aspects of learning and memory and for the exploration of the 
mechanisms that are responsible for these changes at both the synaptic and behavioral 
level.  Along with being involved in normal learning and memory, as well as synaptic 
plasticity, GAG chains and their sulfation moeities play important roles in abnormal states, 
including Alzheimer’s disease, glioma, and the mental deficiencies seen in lysosomal 
storage disorders. 
 Alzheimer’s disease patients show signs of cognitive deficits such as memory loss, 
inability to learn, and confusion.  Currently, there is no positive diagnostic test for 
Alzheimer’s and the diagnosis can only be confirmed upon autopsy.  Alzheimer’s disease 
is caused by the accumulation of neuritic plaques and neurofibrillary tangles in the cortex.  
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One of the major components of the plaques is amyloid protein and co-localized with these 
deposits is highly sulfated heparan sulfate43.  Previous studies have shown that the heparan 
sulfate that co-localizes with these deposits is more highly sulfated than heparan sulfate 
found in other areas of the cortex.  It has also been shown that the source of this highly 
sulfated HS is the nearby neuronal population and that HS is important for regulation of 
the β-secretase (BACE1).  HS and heparin bind to BACE1 and inhibit cleavage of amyloid 
precursor protein (APP)44.  Other GAG chains are found within these plaques, including 
CS and DS, and may contribute to plaque formation and overall progression of the disease.  
HS, CS, and KS can all interact with β-amyloid peptides and enhance the shift of Aβ42 
peptides to the β-sheet confirmation.  GAGs have also been shown to be involved with 
aggregation and precipitation of the fibrils.  This aggregation leads to a loss of solubility 
and increases neurotoxicity.  Low molecular weight (LMW) heparin can compete with 
endogenous HS and inhibit the formation of fibrils45,46.  The sulfate moiety present on the 
heparan sulfate is important for the formation and progression of these neuritic plaques.  
Nonsulfated GAGs have no effect on fibril formation and aggregation46.   
Sulfated GAGs have also been implicated in Alzheimer’s-like changes seen in Tau 
protein.  Incubation of this protein with heparin results in the formation of Alzheimer’s-
like filaments and promotes the phosphorylation of Tau.  This phosphorylation prevents 
the binding of the Tau protein to stabilized microtubules and results in the rapid 
disassembly of microtubules assembled from Tau and tubulin.  The effects seen from a 
variety of GAGs are proportional to the amount of sulfation present on the chain47.     
 Proteoglycans are also involved in a variety of mechanisms for the survival and 
metastasis of glioma.  A glioma is a tumor in the central nervous system that arises from 
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the glia.  For this cancer to be invasive, it must deal with the unique environment of the 
brain, which is fundamentally different from the rest of the body.  For example, the neural 
ECM is naturally resistant to cell and neurite motility.  A major component of this 
inhibitory practice is the presence of CS.  Previous studies show that the CSPG brevican is 
upregulated in gliomas and appears to play a role in cellular dispersion of the glioma.  
Brevican must be cleaved by metalloproteases in order to promote cell motility with the 
cleaved N-terminal being sufficient to promote dispersion48.  HS is also upregulated in 
some gliomas.  HS found in gliomas have been shown to interact with growth factors that 
promote glioma growth and invasion.  Specifically, several of these HS chains promote the 
activity of FGF-2 signaling and its mitogenic properties49.  However, the GAG chains also 
play an important role in glioma progression. 
 Not only the presence of GAG but the sulfation as well can alter the behavior of 
glioma cells.  Studies have examined how sulfation density affects glioma proliferation and 
invasion.  Reduction of sulfation using sodium chlorate treatment on GAGs produced by 
glioma cells resulted in lower levels of cell proliferation50.  Intracerebral inoculation of 
glioma cells pretreated with sodium chlorate also led to a decrease in instances of glioma 
in treated animals and reduced tumor size.  This resulted in longer survival of treated 
animals51.  Changes are also seen in specific sulfation patterns present on HS.  Enhanced 
FGF-2 activity is correlated with higher sulfation levels in the HS present in gliomas with 
a higher amount of 2-O and 6-O-sulfations49. 
 Alterations of normal GAG levels and sulfation are also seen in a variety of other 
neurological disorders, including epilepsy, Parkinson’s, and schizophrenia.  In epilepsy, 
increases in CS and HA are seen in the hippocampus of mesial temporal lobe of patients52.  
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HS has been indicated to be associated with Parkinson’s disease lesions through interaction 
with fibril formation similar to that found in Alzheimer’s disease53.  Increases of CS were 
found in the glia in the amygdala and entorhinal cortex but reductions were seen in the 
extracellular space in these nuclei54.  While GAGs are altered in these disease states, the 
full extent of their involvement in the initiation and progression of these disorders remains 
unclear.  Research into the role of GAG and whether changes in GAG are a symptom, 
cause, or effect of the disease requires further study.  For a full review of GAGs in nervous 
system injury and disease, see Appendix A. 
 
 
1.1.4 Glycosaminoglycans at the neuromuscular interface  
 GAGs are also present in skeletal muscle and at the neuromuscular junction (NMJ).  
As in the CNS, GAG composition in muscle is regulated during development.  CS is tightly 
regulated and controlled during development.  The mouse myogeneic cell line C2C12 
shows that PG expression is modulated during myogenesis.  Changes in sulfation and 
expression affect in vitro mygenesis in myoblasts as well as isolated myofibers.  These PGs 
are also responsible for binding growth factors, which affect skeletal regeneration and 
repair, such as FGF, hepatocyte growth factor (HGF), and TGF-β55.  
 Beyond development, GAGs are involved in skeletal muscle maintenance, 
function, and recovery after injury. After injury to the skeletal muscle, perlecan, glypican, 
syndecan-3, and syndecan-4 are upregulated with transient expression seen 5 to 7 d after 
injury.  Syndecan-3, specifically, is detected earliest. The presence of syndecan-3 in 
myoblast plasma membrane is essential for proper fiber formation in myoblast transplant 
studies, as disruptions of syndecan-3 expression result in a lack of differentiation in 
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myoblasts.  The lack of myoblast differentiation inhibits muscle repair.  This aspect of 
muscle repair is likely a HS-specific effect as decorin, a CS/DS PG, remains unchanged 
during this same timeframe56.  However, CS is not without its importance.  Decorin and 
biglycan can be involved in skeletal muscle regeneration and differentiation, specifically 
in the binding of TGF-β.  TGF-β can inhibit myoblast differentiation after injury.  Both of 
these CS/DS PGs modulate TGF-β availability for transduction receptor binding and this 
modulation of bioavailability of TGF-β is believed to help prevent TGF-β inhibition of 
myoblast differentiation.  Without decorin, myoblasts show an increased binding of TGF-
β to receptors TGF-βRI and TGF-βRII as compared to WT57. 
 GAGs are also involved in the signaling that occurs between neurons and muscle 
at the NMJ.  GAGs are associated with acetylcholine receptor (AChR) organization and 
acetylcholinesterase (AChE) tethering.  The most prominent PG found at the NMJ is agrin.  
Agrin is a HSPG that can be found expressed in both neurons, developing myotubules, 
Schwann cells, and is present in the basal lamina throughout the embryo58.  Named for its 
ability to induce aggregation of a variety of other proteins in the membrane, matrix, and 
ECM, an alternatively spliced form of this HSPG is synthesized by motor neurons and is 
more active than that expressed elsewhere. This alternatively spliced agrin is released from 
the motor neuron into the synapse and is believed to assist in the synthesis of the 
postsynaptic apparatus necessary for muscle innervation by becoming stably associated 
with the basal lamina and aggregating the necessary proteins, such as AChRs, to develop 
and maintain the NMJ58.59. Deficiencies in agrin lead to defective synaptogenesis and 
AChR clustering at the NMJ in mice60.     
 In addition to the clustering of AChR, GAGs are involved with AChE at the NMJ.  
15 
 
In the vertebrate NMJ, there is a concentration of collagen-tailed AChE.  This form of 
AChE consists of three tetramers covalently attached to a collagen-like tail and is 
preferentially expressed where the motor neuron innervates the muscle.  Heparin has been 
shown to solubilize the asymmetric AChE61 and HS is likely to be involved with tethering 
of AChE at the NMJ.  Mice deficient in perlecan, a HSPG found in the ECM, exhibit a lack 
of this form of AChE in the NMJ.  This indicates that perlecan likely serves as an acceptor 
for collagen-tailed AChE and is largely responsible for the localization of collagen-tailed 
AChE.  Perlecan is in turn bound to dystroglycan.  It is this complex that anchors AChE to 
the NMJ62,63. 
 Our knowledge of the effects of HS and CS in skeletal muscle and the NMJ is still 
incomplete.  Knocking out the protein portion of the PG has provided information about 
the overall effect of PGs at the NMJ.  However, this finding does not specify if the effect 
is due to the protein or the GAG chain.  Many of these studies focus on muscle formation 
and innervation during development or muscle recovery after injury55-63 but do not address 
the role GAGs play in the function of healthy adult muscle or how changes in the presence 
of GAG or GAG fine-structure can alter the mechanical or electrical properties of muscle, 
and the results these changes may have in biologically relevant situations such as 
locomotion or vocalization. 
 
1.2 Glycosaminoglycans in speech and song 
1.2.1 Implication of glycosaminoglycans in speech disorders 
 Deafness and resulting communication disorders affect people of all ages around 
the world.  Some causes of deafness can be treated with a cochlear implant.  However, 
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development of language is best facilitated if these implants are done between the ages of 
2 and 6 in children and are coupled with intensive speech therapy.  This age limitation 
reflects a critical period for language learning64,65.  After closure of this critical window, 
the success rate of language acquisition for children with cochlear implants decreases.   
Effective treatment of speech disorders in adults and young children is critically linked to 
neural plasticity and recovery of injury to the vocal fold, but little is known about which 
underlying biochemical functions influence these processes for both the learning of speech 
in children and continued production in adolescents and adults.  
GAGs have been implicated in many different diseases both somatic and 
neurological.  The most obvious circumstance of GAG-induced disease is that of the 
lysosomal storage disorders.  These disorders, called Mucopolysaccharoidoses (MPS), are 
caused by deficiencies in the enzymes that break down GAG chains.  These diseases are 
classified based on the deficient enzyme and often divided further into various syndromes 
based on clinical presentation.  For example, MPS type I is caused by a lack of α-
iduronidase and is further divided into three groups:  Hurler syndrome, Hurler-Scheie 
syndrome, and Scheie syndrome.  The symptoms of these range from severe to mild, 
respectively.  Within these disorders, a variety of developmental and behavioral issues 
arise.  Communication disorders can be seen in these patients.  Children with severe forms 
of MPS type I have been found to have minimal language skills.  This deficit is largely 
attributed to a combination of physical malformations, hearing loss, and developmental 
delays66.  This provides the most direct evidence of the importance of GAG biosynthesis 
for proper development of complex sensorimotor integrated behaviors like speech, and 
alterations in GAG populations leading to long-term deficits or alterations in normal 
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behaviors, like speech.   
 Language delays and communication deficits are often seen in the autism spectrum 
disorders as well.  The BTBR T+tf/J mouse has recently emerged as a model for autism.  
BTBR mice show several autism-like characteristics that strengthen their use as a model 
including: poor social learning, lower level of vocalizations, an unusual repertoire of 
ultrasonic vocalizations during pup separation, and repetitive grooming behaviors.  These 
mice show a reduction in fractone-associated heparan sulfate in the subventricular zone 
(SVZ), suggesting that the presence of HS in the subventricular zone (SVZ) in the lateral 
ventricles is important for normal neuroanatomy as well as behavior67.  This example is 
not the only case that implicates HS in autism-like sociocommunicative deficits.  
Conditional inactivation of the Ext1 in postnatal neurons causes impaired ultrasonic 
vocalizations in mice as well as other autism-like symptoms.  Examining the 
electrophysiology after inactivation shows that HS is required for normal function of 
glutamatergic synapses68.  These studies implicate GAGs in neural control of vocalizations.  
Through changes of enzymes important for GAG biosynthesis or a reduction in SVZ HS, 
vocalizations are altered.   
 
 
1.2.2 Glycosaminoglycans in the vocal organ 
 GAGs are not only important to the neural aspect of vocalizations but also required 
for proper formation and utilization of the vocal organ.  The vocal folds consist of 
connective tissue stretched across the larynx and are capable of self-sustained oscillation, 
which generates sound, including speech.  The vocal folds are attached to both cartilages 
and muscles and their core contains muscle fibers.  The majority of the vocal folds consists 
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of ECM, which gives it its elastic properties and enables rapid movement without physical 
damage.  High-frequency vibratory behavior affects ECM composition. Exposure of 
fibroblasts that were cultured in hydrogels to high-frequency vibrations resulted in altered 
mRNA expression.  Specifically, hyaluronic acid (HA) synthase 2, decorin, fibromodulin, 
and matrix metalloproteinase-1 were temporally up regulated.  The controlled regulation 
of these molecules, which are most commonly found in the ECM, provides evidence that 
ECM development and maintenance responds in part to exposure to vibrational stimuli 
which are common in speech or other vocalizations69.   
 The presence and location of ECM proteins such as PGs are expressed in an age-
dependent manner70,71.  In conjunction with the skeletal muscle controlling the vocal organ, 
arrangement of the ECM in the vocal folds has been shown to play a role in determining 
the biomechanics of voice production72,73.   
 The role of GAGs and ECM in vocal folds can also be seen after injury.  It is 
estimated that voice dysfunction occurs in 3% to 9% of the population at any time.  The 
etiology for these dysfunctions is relatively unknown but injury is believed to be 
responsible in most cases.  These injuries can affect the expression and maintenance of 
ECM components, including GAGs, which may play a role in voice dysfunction74.   
 To study the role of GAGs in vocal learning and production, the use of a good 
model system is required.  Songbirds are one of the few other species in which development 
of species-specific acoustic behavior involves vocal learning.  Songbirds learn songs in a 
similar manner to how humans acquire speech. Using songbirds as a model system allows 





1.2.3 Zebra finch as a model for speech 
Sound production requires complex integration of sensory information and motor 
output filtered and controlled through brain nuclei.  The zebra finch model system is ideal 
as it displays a well-researched timeline and developmental progression.  In oscine 
songbird species, as in humans, vocal learning requires time and rehearsal.  In these cases, 
male juvenile songbirds acquire an auditory template of conspecific song from an adult.  
This auditory template acquisition phase is often the first step in vocal development and is 
followed by a period of rehearsal.  Both the acquisition and sensorimotor phase are usually 
limited by critical periods for vocal ontogeny75.  Again, this mirrors human speech 
development as humans also have a critical period for speech development as evidenced 
by cases of extreme neglect in children76,77 and some cases of deafness78,79 . 
One of the most commonly studied songbirds for vocal learning is the zebra finch 
(Taeniopygia guttata).  In zebra finch, only the males exhibit song learning and production.  
The timeline for the development of song and the neural circuitry for song learning and 
production has been extensively characterized in this species.  Zebra finches are age-
limited or sensitive period learners, and males therefore sing an invariant song after 
reaching adulthood (approx. at age 90 d post hatch, PHD). This age-limited plasticity is in 
contrast to open-ended learners, such as the canary or starling, which can develop new 
songs seasonally even after the first year of life80.  The model used in this thesis is the zebra 
finch model of song. 
Male zebra finches acquire their song in the first 80 PHD using song from one or 
more adult males to which they are exposed81,82.  This timeframe has been broken into two 
critical periods.  The first is a critical period for acquisition of the auditory template.  This 
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sensitive period is between 25 and 50 PHD.  Males begin to generate song-like vocal 
behavior at 28-35 PHD and these songs have poor syllable structure and syntax.  This song 
is then rehearsed by the juvenile until around 90 PHD.  During this time, the song becomes 
more stereotyped and begins to closely resemble the tutor song or songs, which leads to 
crystallization, or the formation of stable adult song.  Crystallization marks the end of the 
second critical period, the sensorimotor period81-84.  See Figure 1.5 for the timeline of zebra 
finch learning. 
The neurological circuits involved in song learning and production in zebra finch 
also have been well characterized.  The neural control system for song production and 
learning consists of many discrete brain nuclei.  Two distinct circuits exist for production 
and song plasticity:  the anterior or learning pathway and the posterior or production 
pathway.  A simplified schematic of these pathways can be found in Figure 1.5.  The 
learning pathways consists of connections between anterior forebrain nuclei and follows a 
hierarchical pathway.  This pathway begins with HVC (proper name), then Area X, the 
medial nucleus of the dorsolateral thalamus (DLM), and the lateral magnocellular nucleus 
of the anterior neostriatum (LMAN).  From LMAN, the information flows to the 
production pathway, which involves the posterior forebrain nuclei, including the robust 
nucleus of the arcopallium (RA) and the hypoglossal motor nucleus (nXIIts).   nXIIts then 
innervates the muscles of the trachea and syrinx, the bird’s vocal organ.  HVC is also 
connected to RA and is considered to be a part of both the learning and production 
pathways85-87.  
Lesions in the learning pathway, with few exceptions, show little effect on 
stereotyped adult song, indicating that this pathway’s primary importance occurs during 
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development.  Evidence from several different experimental approaches, including 
electophyiological recordings, molecular manipulations, and lesions studies, suggests that 
the anterior forebrain learning pathway is not involved in the production of stereotyped 
song in adult zebra finch88,89.   
 
 
1.2.4 Glycosaminoglycans in zebra finch song system 
 The well-characterized and specialized neural circuitry for song production makes 
it particularly well suited for investigating the role of GAGs in the acquisition and 
production of this complex behavior.  As with humans, PGs and sulfated GAGs are found 
in the vocal organ and song system of the zebra finch.  The sound-generating labia in the 
syrinx of the zebra finch, as well as other songbird species, contains collagen, elastin, HA, 
and GAGs.  The presence, distribution, and expression of these molecules may be 
responsible for differences in the fine acoustic structure of song91,92.  Neurologically, PGs 
are involved at every level of vocal ontogeny and production through the presence, 
modification, and interaction with other factors.  Table 1.1 provides an overview of known 
PGs, modifying enzymes, and associated factors found in song-specific nuclei and known 
situations for expression.  
 Both HSPGs and CSPGs are expressed in song-specific nuclei93-97.  Several OST 
enzymes required for GAG biosynthesis are developmentally regulated.  Others such as 6-
OST, sulfatase-2, and chondroitin sulfate glucuronyltransferase appear to be specifically 
regulated during vocal learning93-97.  It is likely that the two major types of GAGs, HS and 
CS, play a major role in song learning and production.  The better studied of the two GAG 
types in song development and production is CS.  HS is present and the enzymes that 
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modify it appear to be developmentally regulated.  CS occurs in the form of perineuronal 
nets (PNNs) in most major song specific nuclei, including LMAN, Area X, HVC, and RA, 
and their expression can be sexually dimorphic.  Whereas PNNs in the nuclei of the anterior 
forebrain pathway were indistinguishable between the sexes, nuclei in the posterior 
pathway in females showed little to no PNN as compared to males103.  PNNs are often used  
as markers for the end of critical periods, and their presence in these nuclei has been linked 
to song development.  The level of CS staining in both HVC and RA was correlate with 
song maturity, with the greatest CS staining seen in RA at the mature song stage.  This was 
true, even if the vocal period was shifted and a lack of CS staining was seen in isolate birds, 
or birds raised without auditory input.  This study served as the first actual characterization 
of the developmental control of GAGs in any song nucleus, noting that total production 
was modulated by vocal development as evidenced by the lack of CS in isolates104.   
 
1.3 Research Objectives 
GAGs serve roles in both the development and production of vocalizations.  Studies 
have linked PGs and GAGs to both the neural and muscular control of vocal learning and 
production.  The existing data infer importance of GAG after injury or correlation of GAG 
presence with learning during development.  Further research is needed to gain a more 
refined understanding of the role of CS and HS in a complex biological system such as 
vocal ontogeny and production.  Our focus is the role of GAGs  in vocal ontogeny and 
production at both the neural and muscular level.  We will be using the zebra finch song 
system as our model of behavior.  However, studying GAGs serves as a challenge.  The 
methods commonly used for GAG manipulation are limited and do not allow for complete 
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comprehension of their role in biological systems.  Our primary goal is to generate GAG 
based biochemical tools to obtain novel insights on vocal development.  Our major 
questions are:  What are the tools available for the manipulation of GAGs and can we 
expand that toolbox?  Will the current tools be effective for in vivo studies of vocal 
production in zebra finch?  How important is the biosynthesis of GAGs during vocal 
ontogeny?  Finally, how do alterations of GAG profiles in syringeal muscles affect 
stereotyped vocalizations?  
To answer these fundamental questions, one needs to create and test an array of 
GAG based biochemical tools.  After creating and validating the molecular tools, two 
approaches are implemented for further investigation. The first approach involves the 
utilization of xylosides, synthetic small molecules that can initiate the formation of single 
CS chains and also serve to inhibit the endogenous GAG production105, to examine the role 
of CS in the RA during vocal development in the zebra finch. The second approach 
involves the utilization of enzymatic degradation to examine how removal of HS from the 
syringeal muscle can change the stereotyped vocalizations in adult zebra finches.  
 
 
1.3.1 Chapter 2  
The production and validation of molecular tools is required for the study of 
glycosaminoglycans in vocal learning and production.    
GAGs have been shown to play important roles in neural development and 
muscular maintenance and function.  In studying these roles, researchers have been limited 
by tools and techniques to examine structure-function relationships, required sulfation for 
binding, and differentiation between the effects of core protein and GAG modulation.  In 
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order to adequately explore these areas of research, it is necessary to create, understand 
and expand the toolbox for glycol-specific manipulations.  For use in the current and future 
studies, we needed to create and characterize small molecules, enzymes, polymers, and 
specifically sulfated oligosaccharides to provide a wider range of understanding about 
specific roles.  To validate that our molecular approach does alter song in our chosen model 
system, the effect of enzymatic degradation of HS in HVC on adult stereotyped song 
production was also investigated.  
 
 
1.3.2 Chapter 3 
Modulation of CS biosynthesis in RA through direct infusion of small molecule 
xylosides leads to a change in vocal ontogeny in juvenile zebra finches.  
 CS has been shown to serve as the marker for the end of critical periods in sensory 
and sensorimotor learning.  In the zebra finch, deposits of CS, in the form of PNNs, appear 
in song-specific nuclei during vocal ontogeny.  The formation of these PNNs appears to be 
dependent upon vocal learning as isolates or birds raised with no auditory feedback do not 
exhibit normal PNN development.  The song-specific nucleus RA shows increased CS at 
the end of the sensorimotor phase of song learning with a complete PNN seen when the 
bird reaches the age of mature song104.  Using a direct infusion of xyloside into RA early 
in vocal ontogeny, we were able to examine how modulating CS biosynthesis during the 







1.3.3 Chapter 4 
Degradation of HS in syringeal muscle alters sound amplitude, pressure, and 
acoustic structure of stereotyped vocalizations in adult zebra finches. 
Complex vocalizations require integration of both neural and muscular control.  HS 
has been shown to be vital to the development and maintenance of skeletal muscle and 
should therefore also play a role in the muscles that control the syrinx.  However, there 
have been no studies to elucidate how the temporary removal of HS alters muscle function, 
such as the superfast muscle of the syrinx, and consequently affects song features.  
Therefore, by employing the use of heparan sulfate lyases, we were able to study how a 
loss of HS in the syrinx alters muscle function, song, and somatosensory systems, revealing 
a complex role of GAG in muscular control of song production.  The results from this study 





Song is a complex behavior that requires complex sensorimotor integration during 
development and our results show that altering GAG biosynthesis early in this critical 
period can alter the developmental trajectory permanently.  Additionally, the role of HS in 
syringeal muscle function indicates that acute changes to muscle activity can have both 
short- and long-term effects on vocal production and provides a unique tool for examining 
the sensitivity of the proprioceptive feedback loop for song.  Both of these results open 
new doors for continued study of GAGs in vocal ontogeny and production with the goal of 
providing new avenues for treatment, therapies, and understanding for those who suffer 
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from communication disorders.  However, to fully understand these results, it is necessary 














Figure 1.1 Examples of the different structures of a few proteoglycans.2 GPI-
linked PGs at the cell surface such as Glypicans, transmembrane proteins 
including syndecans, PGs with globular domains such as aggrecan, and secreted 
PGs such as perlecan, decorin, and biglycan which contain few or many GAG 







Figure 1.2:  Disaccharide units for each type of GAG including all possible sites for 
















Figure 1.4:  The production of PAPS as a substrate for the modification of GAG 
chains.  Two pathways, one in plants, fungi and some animals (red arrows), require 
two separate enzymes while a bifunctional enzyme found in humans and other animals 





Figure 1.5  Timeline and neural circuitry for song learning in zebra finch. (A)  Timeline 
for learning in the zebra finch.  (B) A simplified cartoon of the song system in the avian 
brain. The yellow pathway is the learning pathway.  The blue pathway signifies the motor 




Category Type found in zebra finch brain 
Heparan Sulfate Proteoglycans Syndecan-2,4, similar to 3; 
Glypican-similar to 1,3,4,5,693-97 
 
Chondroitin Sulfate Proteoglycans CSPG2 (versican); CSPG6; 
similar to CSPG5; similar to 
CSPG393-97 
 





Chondroitin Sulfate Modifying Enzymes Chondroitin sulfate 
glucuronyltransferase (found in 
forebrain nuclei during vocal 
learning)95,96 
 
Heparan Sulfate Proteoglycan Associated 
Factors Found in Song Nuclei 
 
Insulin-like Growth Factor98,99; 
wnt99,100; bone morphogenic 
protein (BMPs)99,100 
 
Chondroitin Sulfate Proteoglycan Associated 
Factors Found in Song Nuclei 
TGF-β100,101; Tenascin-R100-102 
 
Table 1.1  Proteoglycans and associated enzymes and factors found in the zebra finch 
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THE PRODUCTION AND VALIDATION OF MOLECULAR  
 
TOOLS FOR THE STUDY OF GLYCOSAMINOGLYCANS  
 






Glycosaminoglycans (GAGs) have been shown to be involved with a wide array of 
biological functions, including:  axon guidance1-4, growth factor binding5-7, receptor 
aggregation8, and coagulation9,10.  While it is understood that GAGs play a role, the 
structural requirements of GAGs for interaction remain unclear.  One of the few known 
carbohydrate structural sequences for protein interaction is the specifically sulfated 
pentasaccharide that binds anti-thrombin III9,10.  Forays have been made into examining 
specific GAG fine structure for the binding of FGFs11,12; however, clear definition of 
structure-function relationships remains elusive.  
This lack of knowledge is due to the restricted set of widely available molecular 
tools with which to study how the structure or biosynthesis of GAGs affects biological 
outcomes.  The most commonly used manipulation involves the use of GAG lyases13-15.  
While these enzymes are effective for showing the importance of GAG in a system, 
enzymatic degradation does not show if there is a specific sulfation pattern that is required,
 nor does it alter biosynthetic production of the GAG.  Additionally, enzymes degrade 
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GAG that is already present and are subject to biological constraints such as temperature 
and degradation or inactivation over time16,17.  As a result, there exists a need for the 
expansion of the molecular toolbox to improve the current understanding of the role of 
GAGs in biological systems. 
 In an attempt to fill this void, the production and characterization of more specific 
enzymes, specifically sulfated polymers and oligosaccharides, and the expansion of a 
library of small molecules, called xylosides, is ongoing.  Both HS and CS consist of 
heterogeneous mixtures that can be selectively cleaved by specific enzymes.  This would 
allow for the study of partial loss of GAG as opposed to complete degradation.  
Additionally, to truly understand structure-function relationships and the minimum 
requirement for interaction, it is necessary to create and maintain a fully characterized 
library of oligosaccharides and polymers.  Finally, monomeric xylosides have been used 
for several decades both in vitro and in vivo.  However, recently, the importance of valence 
has become apparent12.  This has led to a need to expand the library of di-,tri-, and tetra-
meric xylosides.  The focus of this chapter is the production and characterization of 
enzymes, specifically sulfated polymers and oligosaccharides, and xylosides.  To validate 
that the molecular manipulations will function in the zebra finch model system, enzymatic 
degradation in a song specific nucleus was employed.  In this preliminary study, it was 











2.2 Expression and purification of enzymes, polymers, oligosaccharides, 
and the characterization of xylosides 
2.2.1 Production and purification of GAG degrading enzymes  
 
Enzymes are one of the most commonly used methods for the study of the role of 
GAGs in vitro and in vivo.  There are several enzymes that degrade GAG chains.  Hep I,II, 
and III digest HS and heparin.  ChAC, ChB, and ChABC digest CS and DS.  Each of these 
enzymes preferentially digests chains based on a characteristic of the GAG chain.  Figure 
2.1 shows the activity of each enzyme.  Hep I digests unsulfated regions while Hep III 
digests highly sulfated regions.  Hep II digests both sulfated and unsulfated regions16.  
Similarly, ChAC digests chondroitin A and chondroitin C.  ChB digests dermatan sulfate 
while ChABC digests chondroitin A, C, and dermatan sulfate17.  Cloning and producing 
these enzymes allows us to digest specific targets within our area of interest both in the 
brain and in the muscle. 
2.2.1.1 Production and purification of heparan and chondroitin lyase enzymes in E. 
coli. ChB was cloned into a pET_19 vector and transformed into BL21 E. coli.  
Heparitinase I, II, and III were cloned previously into the same vector and strain of bacteria.  
All heparan lyase enzymes and ChB were produced and purified as described below.  A 10 
ml culture of LB broth with 50-100 µg/ml ampicillin was inoculated with bacteria from the 
BL21 stock and grown overnight at 37°C, shaking at 200 rpm.  The next day, the 10 ml 
culture was added to 1 L of LB broth containing 50-100 µg/ml ampicillin and was allowed 
to incubate at 37°C, shaking at 200 rpm until it reached an optical density (O.D.) of 0.6.  
The culture was then treated with 200 µl of 1M IPTG and incubated at 25°C, shaking at 
150 rpm overnight.  The culture is then spun at 4000 rpm for 30 min or until bacteria formed 
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a pellet.  The supernatant was removed. 
The pellet was then re-suspended in lysis buffer (100 mM Tris; 25% w/v sucrose; 
1mg/ml lysozyme; 10 µl DNase; 2mM PMSF) and incubated at 4°C for 30 min.  Next 
Trition-X was added to a final concentration of 0.1% and the mixture was incubated at 4°C 
for 30 min, while being rotated.  The mixture was sonicated for 30 s  
at a pulse rate of 1 s pulse with 2 s intervals.  This was repeated thrice.  The sonicated 
mixture was spun at 15000 rpm for 30 min at 4°C.  The supernatant was then filtered 
through a 0.45 micron filter.  The filtrate was purified for 6-His tag labeled protein using a 
Nickel (Ni) column.  The column has a bed volume of 3 ml/ l of culture.  The column was 
washed with 4 column volumes of water and equilibrated with 4 column volumes of wash 
buffer (100 mM Tris, pH 7.5; 0.5M NaCl; 5% v/v glycerol; 20 mM Imdazole; 5 mM 2-
thioethanol).  The filtrate was loaded onto the column thrice, washed with 30 column 
volumes of wash buffer, and then eluted using a linear gradient of elution buffer (100 mM 
Tris, pH 7.5; 0.5M NaCl; 5% v/v glycerol; 500 mM Imdazole; 5 mM 2-thioethanol) 
concentrated and buffer-exchanged into protein buffer (10 mM PIPES; 5% glycerol) using 
a 10 kDa MWCO Amicon column.   
2.2.1.2 Confirmation of enzyme and activity.  After purification, all enzyme batches 
were tested for protein concentration, the presence of desired enzyme, and rate of enzyme 
activity.  The presence of enzymes was confirmed by western blot (Figure 2.2A).  To assess 
protein concentration, a BCA was run on each sample.  Concentrated sample was tested 
undiluted and at various dilutions to ensure that our concentrations did not fall at the 
extreme ends of the standards.  All samples and standards were run in triplicate.  
Concentration was calculated using the standard curve created with known concentrations 
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of bovine serum albumin (BSA).  
An activity assay was conducted to examine the enzymatic activity present in the 
sample (Figure 2.2B).  All heparitinase and chondroitinase enzyme activity can be 
measured by increasing absorbance at 232 nm.  This is due to the formation of a carbon-
carbon double bond when the enzyme cleaves between sugar residues.  Using overall rate 
of increase, each enzyme batch can be normalized so aliquots have approximately equal 
activity.   Each enzyme was run with the polymer that provided the most efficient cleavage.  
Hep I was tested with heparosan, HepII with N-sulfated heparosan, Hep III with Heparin, 
CsAC with chondroitin A or C, CsB with dermatan sulfate, and CsABC with a mixture of 
chondroitin A, C, and dermatan sulfate.  A negative control, a polymer that the enzyme did 
not digest, was also run to exclude the possibility that increase in 232 nm was seen due to 
factors not related to GAG polymer cleavage.  Active enzyme was aliquoted into 10 µl 
aliquots and stored at -80°C until needed.   
 
 
2.2.2 Production, purification, and characterization of modified polymers and 
oligosaccharides 
While degradation allows us another avenue of study, it is still an incomplete 
method.  In order to truly understand structure function-relationships, it is necessary to 
control several aspects of the GAG chains, including the size and sulfation pattern.  This 
work often begins in vitro and requires the production of HS polymers that are specifically 
sulfated.  Additionally, these polymers can be broken down into oligosaccharides through 
controlled degradation.  The production of these oligosaccharides from the starting 
polymers provides a method for the study of the minimum requirement for interaction.  
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These oligosaccharides can also be modified to produce specific sulfation patterns that may 
be useful. 
2.2.2.1 Preparation of oligosaccharides. Commercial heparin was purchased and 
partially digested through the addition of Hep III enzyme.  A 15 ml, 100 mg reaction was 
set up and digested through the addition of Hep III enzyme to the reaction and immediately 
spun at 4000 rpm for 45 min in a 20 kDa MWCO Amicon column.  The flow-through was 
collected and lyophilized.  This process was repeated for several hundred milligrams.  The 
lyophilized sample was rehydrated in 10 ml of ddH2O.  The oligosaccharide mixture was 
separated on a preparative Carbopac column (22 x 250 mm) by HPLC. The 
oligosaccharides were eluted with a gradient of 2 M NaCl (pH 3.5) for 90 min at a flow 
rate of 10 ml/min and monitored by absorbance at 232 nm.   
Each peak represented an oligosaccharide of different degree of polymerization 
(Dp) and sulfate density.  Fractions were collected at a rate of 5ml/30s.  Those containing 
each size and sulfate-defined oligosaccharide were pooled together and desalted using a G-
25 column (1.5 cm x 50 cm).  The size and sulfation of each desalted oligosaccharide was 
confirmed by mass spectrometry (LC-MS).  
Heparosan and N-sulfated heparosan oligosaccharides were prepared in the lab and 
partially digested by Hep I following the previously listed procedure with the exception of 
using a linear gradient of 1 M NaCl (pH 3.5).       
2.2.2.2 Enzymatic modifications of HS polymer or oligosaccharide. 1mg of 
polymer (heparosan, N-sulfated heparosan, N- and O-sulfated heparosan, heparin) or 
desired oligosaccharide was incubated with 40 μl of desired OST enzyme (~1 mg/ml) and 
800 μg of PAPS in a total volume of 1 ml. The reactions were performed at 37°C for 24 h 
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in MES buffer (25 mM MES, pH 7.0, 0.02 % Triton X-100, 2.5 mM MgCl2, 2.5 mM 
MnCl2, 1.25 mM CaCl2, 0.75 mg/ml BSA). The reaction mixtures were purified through a 
DEAE-sepharose column (0.25 ml) that had been pre-equilibrated with wash buffer (20 
mM NaOAc, 0.1 M NaCl, pH 6.0). After washing with 30 column volumes of wash buffer, 
the bound HS was eluted with 6 column volumes of elution buffer (20 mM NaOAc, 1 M 
NaCl, pH 6.0). The samples were desalted and concentrated with 3000 MWCO Amicon 
columns.  Samples were then lyophilized, weighed, and reconstituted to a concentration of 
1 mg/ml.  50 μg of polymer was digested with Hep I,II,III and modifications were analyzed 
by mass spectrometry or HPLC.  50 µg of oligosaccharide was analyzed by mass 
spectrometry without digestion. 
2.2.2.3 Mass spectrometry analysis of oligosaccharides and polymers. The di- and 
oligosaccharides were analyzed using a capillary C18-HPLC column (0.3 x 30 mm) 
coupled to an electrospray ionization time-of-flight MS (Bruker Daltonics, USA). The 
oligosaccharides were eluted with a linear gradient of acetonitrile at a flow rate of 5 μl/min 
for 30 min.  Dibutylamonium acetate (5 mM) was used as an ion-paring agent. The MS 
was acquired in the negative ion mode at the following conditions: cone gas flow rate at 50 
l/h, nozzle temperature at 130°C, drying gas (N2) flow rate at 450 l/h, spray tip potential 
at 2.3 kV, and nozzle potential at 35 V. 
2.2.2.4 Confirmation of oligosaccharide production.   Heparin oligos are confirmed 
after HPLC strong anion-exchange on a preparative scale (Figure 2.3).  The first and largest 
peak in the HPLC trace contained fully, or tri-sulfated, disaccharides, indicating that 
heparitinase enzymes may prefer exolytic cleavage of polymer.  In uniformly sulfated 
polymers such as heparosan or N-sulfated heparosan, this disaccharide (dp2) peak 
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remained the largest and all subsequent peaks correspond to higher oligosaccharides that 
differ by one disaccharide.  If the first peak is a disaccharide, or dp2, then subsequent peaks 
are dp4, dp6, dp8, and so on.  However, in heparin oligosaccharides, this is not always the 
case.   
Heparin polymers have highly sulfated, nonsulfated, and moderately sulfated 
regions.  This presents an opportunity for differentially sulfated oligosaccharides.  The 
highest level of sulfation seen in heparin is three sulfates per disaccharide; however, two, 
one, or none is also possible.  This gives us the possibility of four different disaccharides, 
seven different tetrasaccharides, ten different hexasaccharides, and so on.  This makes 
complete separation more difficult.  In the heparin digest, the first peak was pure tri-
sulfated disaccharide.  The second peak, when analyzed by mass spectrometry, shows that 
it contains less sulfated dp4 molecules.  The third peak was where the fully sulfated dp4 is 
located.  Therefore, it is important to characterize each peak separately to ensure that it is 
the correct size and sulfation density.  Figure 2.4 shows the mass spectrometry analysis of 
several heparin oligosaccharides.  The enzymatic synthesis of polymers allows for the 
preparation of specifically sulfated HS-like polymers.  Table 2.1 shows all structures that 
have been chemoenzymatically synthesized.  These molecules are available for 
experiments that are beyond the scope of this work.   
 
 
2.2.3 Priming analysis of click-xylosides 
Previous studies have found the addition of xylose residues attached to an aglycone, 
called xylosides, can induce the formation of GAG chains without the presence of a core 
protein18-20.  Alteration of the aglycone attached to the xylose can alter the priming activity 
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of the molecule as well as the type, sulfation pattern, and molecular weight of the primed 
GAGs18-20. The most commonly studied xylosides have been the O-xylosides. O-xylosides 
are often unstable, so alternative types of xylosides are currently being explored18-20.  
Promising sets of new xylosides, called click xylosides, are formed by copper (Cu) (I)-
catalyzed click reactions. Stable in culture and in vivo, recent studies have examined how 
these click xylosides induce GAG formation and how alteration of the aglycone can change 
the primed GAGs19,20.  Libraries of these molecules have been synthesized and tested.  
Monomeric xylosides, or molecules containing a single xylose residue, represent the 
majority of xylosides that are screened.  One of these molecules which has been shown to 
prime only CS at a high level will be used in Chapter 3.  Should the small molecule 
approach for study of GAGs in a biological system show promise, it is important to have a 
variety of xylosides with different structures and priming capabilities.  Xylosides that 
contain multiple xyloside residues, such as dimeric xylosides, may be more analogous to 
endogenous PGs.  This may allow for a more accurate study for the separation of GAG and 
protein activities.  Dimeric xylosides can be synthesized using click chemistry as well, but 
often show lower priming capabilities.  The reduction in priming necessitates continued 
exploration of dimeric xylosides and how changes in structure may result in better activity.  
To examine this, we compared Cu-click dimeric xylosides and dimeric xylosides made 
using a ruthenium (Ru) catalyst. 
2.2.3.1 Methods and materials. The chinese hamster ovary (CHO) cell line (pgsA-
745) was obtained from American Type Culture Collection.  All cell culture reagents were 
obtained from Invitrogen.  The radiochemical, 35S-Na2SO4, and the flow scintillation 
cocktail, Ultima-FloAP, were obtained from Perkin Elmer Life and Analytical 
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Sciences.  The 6X pronase solution was prepared using Streptomyces griseus protease type 
XIV (1 mg/ml).  The DEAE-sepharose gel was purchased from Amersham 
Biosciences.  The high pressure liquid chromatographpy (HPLC) column involved for 
anion-exchange chromatography was the DEAE-3SW (7.5 mm x 7.5 mm, 10 µm), for size-
exclusion chromatography was the G3000SWXL (7.8 mm x 30 cm, 5 µm), and for 
chondroitin sulfate disaccharide analysis was the TSKgel SAX (6 mm x 15 cm, 5 µm).  All 
columns were purchased from Tosoh Bioscience LLC.  The HPLC column used for 
heparan sulfate disaccharide analysis was the CarboPac Analytical PA1 (4 mm x 25 cm, 
10 µm) column from Dionex.  Amicon Ultra-0.5 ml centrifugal filters (3000 MWCO) were 
purchased from Millipore.  Compounds were sent from Gifu University in Japan.  
Structures can be found in Table 2.2. 
To determine the ability of xylosides to prime the synthesis of glycosaminoglycans 
in culture, experiments were performed in vitro using the CHO cell line pgsA-745.  Cells 
(1x105 per well) were plated in appropriate medium in a 6-well plate.  The cells were 
incubated in a humidified incubator at 37∘C for 48 h to a confluency around 50%.  After 
being washed with sterile phosphate buffered saline (PBS), appropriate medium containing 
10% dialyzed fetal bovine serum (FBS) (989 µl) was added to each well along with 1 µl of 
100 mM concentration of specific xyloside (final concentration of primer is 100 µM), and 
100 µCi 35S-Na2SO
4. The plates were then placed in the incubator for 48 h before 6 x 
pronase solution was added, and the plates were incubated overnight at 37∘C. 
After incubation with pronase, the entire contents of each well were transferred to 
a microcentrifuge tube and spun at >12,000 x g for 10 min.  The supernatant was transferred 
to a clean tube and then loaded on to a DEAE-sepharose column (0.25 ml) that had been 
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pre-equilibrated with 10 column volumes of wash buffer (20 mM NaOAc buffer, pH 6.0, 
containing 0.1 M NaCl).  Next the column was washed with 20 column volumes of wash 
buffer.  Elution of the bound GAG chains from the column was accomplished using 6 
column volumes of elution buffer (20 mM NaOAc buffer, pH 6.0, containing 1 M NaCl) 
and the amount of GAG chain primed was determined by quantifying 35S-radioactivity 
incorporated into the eluted GAG chains.  50 µl of the elution was added to 5 ml of 
scintillation cocktail and measured for total radioactivity using a scintillation counter.   
The extent of sulfation of primed GAG chains was determined by assessing 
migration time on an anion-exchange column using HPLC with inline flow scintillation 
analyzer.  Each elution was desalted using a 3000 molecular weight cut off (MWCO) spin 
column at <12,000 x g centrifugation.  The remaining 100 µl was diluted to 200 µl 
total.  150 µl was loaded onto a HPLC-DEAE column and eluted with a linear NaCl 
gradient of 0.2 M to 1 M. 
Primed GAG chain length was determined by assessing their migration time on a 
size exclusion column using HPLC with inline flow scintillation analysis.  Two 
G3000SWXL (7.8 mm x 30 cm, 5 µm) size exclusion columns were connected in tandem 
and the eluted GAG chains were loaded onto the columns.  These chains were eluted over 
60 min using a phosphate buffer containing 100 mM KH2PO4 and 100 mM NaCl at pH 
6.0.  The size was calculated based on comparing the migration time of polystyrene 
sulfonate standards with the calculated migration time of primed GAGs (average of peak-
width at half maximum). 
Primed GAG chains were digested using heparitinase I, II, and III (Hep I, II, III) or 
chondroitinase ABC (ChABC) at 37∘C overnight.  Samples were then boiled to inactivate 
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enzyme and centrifuged at >12,000 x g for 10 min.  The supernatant was transferred into 
HPLC vials and samples that had been digested by Hep I, II, III were loaded onto the 
CarboPac PA1column.  Samples that were digested by ChABC were loaded onto the 
TSKgel SAX column.  Both the Hep I,II, III and CsABC samples were eluted over a 1M 
NaCl gradient, pH 3.5, and compared to standards. 
2.2.3.2 Results of priming analysis.  Two sets of dimeric molecules were 
synthesized and then assessed in an in vitro model of GAG priming (Table 2.2).  All 
molecules were tested for their priming ability using previously described techniques19,20.  
As determined by S35 incorporation, both Cu- and Ru-click xylosides primed but there were 
distinct differences in priming between 1,4 and 1,5-xylosides (Figure 2.5). Dimeric 
xylosides synthesized using Ru-click chemistry showed higher priming activity when 
compared to their Cu counterparts.  
After assessing the priming activity of the molecules, the primed GAGs were 
characterized. Examination of sulfate density showed all compounds primed highly 
sulfated GAG chains.  Primed GAGs elute at similar times in weak-anion exchange HPLC 
(Figure 2.6A), regardless of method of synthesis and length of the carbon linker.  After 
determining sulfation density, the size of the primed GAGs was assessed (Table 2.3). While 
the primed GAGs showed slight differences in size, these differences were not significant. 
Finally, the disaccharide compositions of the primed GAGs were analyzed (Figure 2.6B). 
All molecules produce primarily CS GAG chains.  After digestion of these chains using 
ChABC, the disaccharide profiles show that the primary disaccharide produced is a mono-
sulfated disaccharide.  It is the same disaccharide for each molecule.  In Cu-click xylosides, 
the length of the linker between xylose residues plays a role in priming as there appears to 
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be a negative correlation between the length of the linker and the priming activity of the 
molecule. However, this is not as clear in the Ru-click xylosides. The compound with the 
three and four carbon linker (4a, 4b) show similar priming activity with a reduction in 
activity seen in the molecules containing the five carbon linker (4c).   
The data show that Ru-click chemistry produces more potent dimeric xylosides and 
the length of the carbon chain linker may influence 1,4 Cu-mediated orientation of the 
xylosides more than the 1,5 orientation found in Ru-mediated xylosides.  The obvious 
difference in priming activity shows that the triazole linkage is important for priming 
activity. Changing from a 1,4 to a 1,5 linkage may provide the molecule with a higher 
percentage of entry into the cell and Golgi. Further exploration of how alterations to the 
aglycone linking the xylose residues coupled with a 1,5 linkage would alter both priming 
activity and GAG structure are needed.  While Cu-click chemistry has been the 
predominant method for the synthesis of click-xylosides, the increased priming activity of 
the dimeric Ru-click xylosides versus the dimeric Cu-click shows a need to explore other 
forms of click chemistry for more active xylosides. 
2.2.3.3 Summary of xyloside priming analysis.  The production, purification, and 
characterization of a variety of tools is necessary for the proper study of the role of GAGs 
in biological systems such as vocal ontogeny and production.  This chapter serves to 
present several different methods for GAG manipulation and show how these molecular 
tools were produced.  The use of enzymes in exploration of GAGs is the most common 
molecular manipulation13-15.  The cloning, expressing, and purification of enzymes 
provides the intial step for examining the importance of GAGs in neural and muscular 
control of behaviors.  The use of Hep I, II, III together or ChABC results in the 
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degradation of all HS or CS, respectively.  Using a single heparitinase or ChAC or ChB 
would allow the selective degradation of specific structures for the study of the role of 
specific GAGs.  Hep I, II, III enzymes were employed in this chapter as well as Chapter 
4.  Based on the results, further exploration can be conducted using a single or mix of two 
enzymes.  Additionally, the use of chondroitinase enzymes can also be examined in 
future studies as well. 
Enzymatic degradation, while the most common, may not provide structure-
specific information for GAG interactions, especially in regards to the sulfation patterns of 
heparan sulfate.  Studying sulfation patterns requires controlling GAG structure.  For HS, 
controlling sulfation pattern can be done chemically, but is a long and arduous process21.  
Chemoenzymatic synthesis of HS is a less exacting, but more scalable, method for creating 
specifically sulfated polymers.  By enzymatically modifying the HS backbone with OSTs 
allows for the production of polymers with a single, two, or three specific sulfations.  These 
specifically modified HS polymers can then be used to examine structure-function 
relationships.  Similarly, oligosaccharides produced from these polymers will allow the 
study of the minimum requirement for GAG function.  Several of these molecules have 
been or are being used by collaborators in other areas of study such as cancer, coagulation, 
and the development of nano-sensors (see Appendix B for published material).  Future use 
of these molecules in vocal research is currently being discussed.  
Small molecules present another method for GAG manipulation.  Xylosides are 
small molecues that can alter GAG biosynthesis in vitro and in vivo12,18-20.  These molecules 
are constantly being synthesized and screened for priming activity and GAG type.  A 
monomeric xyloside that has been characterized19 and used in vivo12 in a different model 
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system will be used in Chapter 3.   This molecule primes at a high level and primes only 
CS.  The specificity of this molecule allows the modulation of a single type of GAG that 
is known to be expressed during this period in development.  As compared to enzymes, 
which only digest present GAGs, using xylosides allows us to modulate biosynthesis itself, 
not simply alter GAG chains present in the ECM and on the cell surface.   The use of 
multimeric xylosides is a viable option for future research; however, continued screening 
for molecules that prime well, produce a single type of GAG (HS or CS), produce both HS 
and CS, or produce a specific sulfation is required to allow for a better understanding of 
exactly how GAGs function in vivo. 
 
2.3 Degradation of HS in HVC leads to altered song in adult zebra finch 
After creating a variety of tools for the study and characterization of GAGs, we 
wanted to verify that manipulation of GAGs in a song-related forebrain area would lead to 
a measurable behavioral change in the zebra finch.  The most straightforward test was to 
use the most common method of GAG manipulation, enzymes, and target a song-specific 
nucleus known to contain a PG.  The literature is limited in this area, consisting of a handful 
of papers that directly mention HS or CS.  Two of these papers focus on the role of PNNs 
during vocal ontogeny and will be discussed in the next chapter.  A proteomic overview of 
the telencephalic sensorimotor nucleus, HVC (used as proper name), points out that a 
HSPG is present and is presumably involved in neural connectivity, differentiation, and 
neuronal survival in the adult zebra finch23.  Outside of these studies that directly mention 
PGs, there are many publications that express the importance of growth factors and other 
signaling molecules in song development and production24-27.  Many of these molecules, 
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such as BMP28, FGF12, and SHh29, are regulated or interact with GAGs in other systems.   
 This direct and indirect evidence led us to examine whether degradation of HS in 
HVC causes changes to adult stereotyped song.  The proteomic study states that HS is 
likely involved with integration of neurons into circuits and neuronal survival23.  If that is 
the case, then disruption of the HS should lead to changes in song, which should be 
detectable as adult song is highly stereotyped.  This provides a test of whether GAGs are 
important for neural control of song production in adult. 
 In summary, examining of the role of HS in HVC in controlling adult song 
production will provide the preliminary evidence to confirm our choice of model system 
and employ other techniques to examine GAG influence in song learning and production 
 
 
2.3.1 Methods and materials 
 2.3.1.1 Subjects. All male zebra finches used in this study were bred in our aviaries. 
The surgical procedures used were in accordance with National Institutes of Health 
guidelines and the Animal Care and Use Committee at the University of Utah.   
2.3.1.2 Procedure for injection of enzyme into HVC.   Heparitinase enzymes were 
produced, purified, and characterized as described previously.  Adult male zebra finches 
(120+ PHD) were housed individually in acoustic chambers and song was recorded for 
several days, or until at least 20 distinct motifs were recorded.  Birds were then anesthetized 
with Ketamine/Xylazine (0.012-0.02 ml), restrained with a cloth jacket, and placed in a 
stereotaxic apparatus with the horizontal head axis 45° relative to the vertical axis of the 
instrument. A small area of the skull was removed and an opening was made bilaterally in 
the dura 1-1.4 mm lateral to Y0.  Birds received an acute injection (5 µl, at a rate of 1 
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µl/min) bilaterally of Hep I, II, III enzyme mixture (n = 6) or buffer (n = 6) at 0.4 mm depth 
from the brain surface.  The exposed tissue was covered with hydrophilic vinyl 
polysiloxane (Reprosil; Dentsply International Inc.) and the polymer was then fixed to the 
skull using dental cement (Dentsply International Inc).  After surgery, each bird was 
returned to individual housing for recovery.  After recovering from surgery, birds were 
recorded in their acoustic chambers. 
2.3.1.3 Recording and analysis of song. The songs of birds from both enzyme 
treated and sham groups were recorded weekly after infusion.  All songs were recorded 
digitally using an omni-directional microphone (Audiotechnica) and software from Avisoft 
(SASLab, Berlin, Germany).  At least 20 song motifs from each bird were selected 
randomly from the recordings made each week and spectrographic represntations were 
visually inspected for changes in song structure.  Variability within the adult song was 
assessed as changes in syllable sequence and acoustic structure using Sound Analysis Pro 
(www.soundanalysispro.com), and Praat (www.praat.org).  
 
 
2.3.2 Analysis and interpretation of changes in song 
 Birds that received a sham infusion showed no change in song.  Motifs and bouts 
remained stereotyped and syllable structure remained unchanged.  Enzyme treated birds, 
however, showed a wide range of changes within a month after treatment.  These changes 
ranged from changes in harmonic emphasis and changes in timing between syllables to the 
production of entirely novel syllables and motifs. 
 An example of changes in harmonic emphasis is shown in Figure 2.7.  Typical 
adult zebra finches present a stereotyped pattern of harmonic emphasis, or emphasis of 
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specific frequencies within a syllable.  This is maintained between bouts and motifs.  
After treatment, this emphasis began to shift.  Interestingly, the energy in the lower 
frequencies was reduced while higher frequencies were emphasized.   
In terms of timing, it there was an obvious change in the timing between specific 
syllables in some of the treated individuals.  Figure 2.8 shows an example of such a change.  
In this instance, the intersyllable interval between two syllables was shortened one month 
after treatment, whereas it was relatively invariant before treatment.  Timing changes were 
observed in 3 out of 6 individuals, while sham infusion birds did not show such a change.  
Finally, novel syllables appeared in the motifs of 4 out of 6 birds at one month post-
treatment.  In many cases, it was a single syllable that appeared occasionally in motifs but 
in the rare case, an entirely new motif was constructed and added to the end of pre-existing 
stereotypic song (Figure 2.9). Although this analysis was a test of concept only, it became 
apparent that not only are GAGs involved in neural control of vocal production, but loss 
of these carbohydrates can alter song output in a myriad number of ways.  This was further 
complicated by the fact that treated birds did not always display the same characteristic 
changes in song, or if similarities were observed, it was with a wide range of severity.  This 
was no more apparent than in the formation of new syllables.  Not all birds created novel 
syllables, some created a single syllable that was rarely seen in motifs, others a single 
syllable that appeared more frequently, or another that produced an entirely new motif that 
was frequently added to the end of the pre-existing stereotypic motif.  This makes 
quantification and complete understanding of the data and the importance of HS in zebra 
finch song production difficult and further emphasizes the need for a more sophisticated 
tool for studying how GAGs affect neual function and control of sensorimotor systems 
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such as that of learned vocal behavior. 
 
2.4 Discussion 
 While GAGs have been implicated in almost every biological system, there is still 
only superficial knowledge of the exact functions of these complex carbohydrates in these 
systems.  One of the major reasons for this is the dearth of tools that exist to study and 
really understand the structure and function of GAGs and the importance of specific 
structures to specific functions.  GAGs are not easily sequenced, as they are formed in a 
nontemplated process with several steps of modification that can, but are not required, to 
occur.  These differences in length and sulfation can lead to largely heterogeneous 
structures with numerous possible functions.  In order to better understand how they 
function, specific tools for study are required.  
We set about to create this toolbox and show basic application in vivo of how 
degradation of one type of GAG can lead to a multitude of behavioral outcomes that are 
specific to individuals.  Unlike a protein knockout, which may produce universally specific 
symptoms, removal of a specific type of GAG in the brain, such as HS, can lead to a variety 
of different outcomes.  This shows that understanding the interaction between GAGs and 
proteins is vital for a complete understanding of how the brain connects, develops, and 
functions in both normal and diseased states.  Using a variety of enzymatic and chemical 
methods, we were able to produce several reliable and novel molecules for studying GAGs.  
By producing, purifying, and screening enzymes, HS-like polymers, and oligosaccharides, 
and small molecules, we have been able to expand our capabilities to examine the function 
of GAGs in biological systems.   
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These tools, while shown to be active in vitro and in other systems, had yet to be 
tested in our desired model system.  With the production of enzymes, we are able to look 
at overall degradation and how the loss of GAG may affect behavioral outcomes, as seen 
in changes in a stereotyped behavior such as crystallized song production in the zebra finch.  
The application of heparitinases in vivo led to a multitude of behavioral outcomes, specific 
to individuals, which shows that small changes can have profound but diverse effects.   
The diversity of these changes implicates GAGs and GAG-protein interaction 
factor into several aspects of neural development and plasticity.  Small and transient 
changes in GAG profiles in the brain can result in a variety of changes to a stereotyped 
behavior.  The variety of outcomes also emphasizes the importance of understanding 
exactly how GAGs function in vivo and how important sulfation pattern is to specific 
outcomes.  The production and characterization of xylosides allows us to create molecules 
that can alter GAG biosynthesis and possibly serve as mimics for the naturally occurring 
proteoglycans.  The creation of a library of specifically sulfated polymers and production 
of their oligosaccharides also presents a unique tool for understanding the optimum and 
minimum requirements for protein-GAG interaction.  Each of these provides a different 






Figure 2.1 Specificity for enzymatic degradation by Heparin lyases.  Hep I digests 
primarily unsulfated HS polymer, Hep II digests sulfated and unsulfated HS, and Hep 










Figure 2.2  Purification and activity of glycosaminoglycan degradation enzymes. 
(A) A western blot that has been probed with anti-HIS tag antibody shows the 
presence of heparatinase enzymes.  (B) Activity of Hep III is observed with the 






Figure 2.3 HPLC profile of preparative scale partial digestion of heparin to produce 
oligosaccharides.  Unlike uniformly labeled polymers, peaks must be characterized to 







Figure 2.4 Mass spectrometry analysis of heparin oligosaccharides.  Strong anion 
exchange HPLC separates sulfated oligosaccharides based on their degree of 
polymerization (dp).  Peaks correspond to different size or sulfated molecules.  (A) 
Fully-sulfated disaccharide is present as seen in the peak at 575.993, z1.  (B)  Fully-
sulfated tetrasaccharide can be seen at the same peak, 575.953, z2.  (C)  As the size of 
the oligosaccharide increases, often the mass at which you see the molecule increases 


















































Figure 2.5  Comparison of priming activity by scintillation count for Cu-click vs Ru-
click xylosides.  This shows the incorporation of radioactive sulfate in GAG chains 
primed by Cu-click dimeric xylosides (3a,3b,3c) and Ru-click dimeric xylosides 
(4a,4b,4c).  Ru-click xylosides show higher priming in all compounds tested and do 



























Figure 2.6. Comparison of overall sulfation density and disaccharide composition for 
Cu-click and Ru-click xylosides (A) weak-anion exchange HPLC profiles of GAG 
chains primed by Cu-xylosides (3a,3b,3c) versus Ru-xylosides (4a,4b,4c).  This shows 
that sulfation density of the primed GAG chains is similar for all compounds.  (B) 
Disaccharide composition of primed GAG chains as measured by strong-anion 







































































































































































































































Figure 2.8 .  Spectrogram analysis indicates a shift in timing between song syllables 
in enzyme treated birds as compared to controls.  This change can be seen one month 









Figure 2.9 Production of a novel motif at one month post heparitinase injection in adult 
zebra finch.  The original motif, boxed in blue, is stereotyped and was present prior to 
enzymatic manipulation of HVC as seen by the pre-infusion song presented on the left.  
One month after treatment, the treated bird consistently produced a novel motif, outlined 
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CHAPTER 3  
MODULATION OF GLYCOSAMINOGLYCANS ALTERS  
 





In the brain, PGs function to form PNNs1-4, bind morphogens and ligands to form 
gradients5,6, have strict developmental regulation7-9, and are involved in axon 
pathfinding10, neuron migration, and connection11-13.   While the importance of the 
biosynthesis of GAGs in sensory system critical periods, such as vision, have been 
studied14-16, research has yet to consider their role in more complicated aspects of neural 
control such as systems and behaviors that require a large degree of sensory-motor 
integration.  One such behavior is songbird vocal behavior. 
 In zebra finch, vocal ontogeny has been well documented.  Both the timeline17-19 
and the neural circuitry for learning and producing song in zebra finch has been well 
characterized18,20-22. Song is developed by obtaining an auditory template, rehearsal and 
refinement of song, and finally crystallization of song into stereotyped motifs, which 
occurs around 90 PHD17-19.  However, the importance of GAGs in this process and how 
changes in GAG biosynthesis affect overall vocal ontogeny is still unclear.  
Vocal ontogeny requires integration of sensory (auditory) feedback with a motor 
(song output) system through central processing in specific nuclei in the forebrain23-25.   
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This provides a system uniquely designed to allow us to examine how altering GAG 
biosynthesis in the central control can affect sensorimotor integration.  In this manner, it is 
possible to examine how GAG biosynthesis contributes to complex behavior and 
modulation of carbohydrate polymers can result in altering a distinct behavior.  This study 
presents the first evidence that modulations in GAG biosynthesis in the central nervous 
system during development can have long lasting effects on complex learned behaviors 
that require sensorimotor integration, such as learned vocal behavior.  
 
 
3.2 Methods and materials 
3.2.1Animals 
 Juvenile male zebra finches were used in this study.  The birds were bred in flight 
aviaries at the University of Utah. The surgical procedures used were in accordance with 
National Institutes of Health guidelines and the Animal Care and Use Committee at the 
University of Utah. 
 
 
3.2.2 Reagents  
  Immunohistochemistry was performed using Hoechst 33342 (Fisher Scientific).  
Western blots were conducted with monoclonal antibody CS56 (Sigma Aldrich).  All 
secondary antibodies were purchased from Fisher Scientific.  Xylosides were synthesized, 







3.2.3 Surgery and microinjection 
Birds were anesthetized with (0.012-0.02 ml) of Ketamine/Xylazine, restrained 
with a cloth jacket, and placed in a stereotaxic apparatus with the horizontal head axis 45° 
relative to the vertical axis of the instrument. A small area of the skull was removed and 
an opening was made in the dura 2 mm lateral and 1.4 mm posterior to Y0 bilaterally as 
determined by a stereotaxic atlas in lab.  A precut 1.5 mm 26G guide cannula (Plastics One, 
Roanoke, VA) was implanted and a 33G dummy cannula inserted to prevent blocking of 
the guide cannula.  The cannulae were fixed at the skull with dental cement (Dentsply 
International Inc).  After surgery, each bird was housed individually for recovery.  After 
recovering from surgery, birds were moved to an accoustic chamber for song recording.  
Microinjections were given according to their experimental group every 48 h for a total of 
5 injections beginning at 55-60 PHD in all birds.  Injection sites were confirmed by 
histology after perfusion.  Immediately before injection, the dummy cannula was replaced 
by a 33G internal cannula, which was connected via tubing to a syringe.  Microinfusion 
was driven by a microinfusion pump (KD Scientific, New Hope, PA). Each injection was 
performed bilaterally to a total injeciton volume of 5 µl at a rate of 1µl/min.  The bird was 
then returned to the accoustic recording chamber for continued song recording. 
 
 
3.2.4 Song recordings and analysis 
The songs of birds from both experimental and control groups (n= 6 experimental, 
6 control) were recorded from the date of first microinjection to 110+ PHD.  All songs 
were recorded digitally using an omni-directional microphone (Audiotechnica) and 
software from Avisoft (SASLab, Berlin, Germany).  At least 25 song motifs from each bird 
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were selected randomly from the recordings made during the recording period.  
Spectrograms of these motifs were used to analyze the variability of adult song through 
analysis of the sequence of syllables and the syllable morphology using Sound Analysis 
Pro (www.soundanalysispro.com).   All birds sang readily in the recording chambers.  To 
quantify the degree of stereotypy in the song phrases of control and experimental birds, 30 
motifs were examined from each of three timepoints:  60-70 PHD, 80-90 PHD, and 110+ 
PHD.  Each motif was analyzed using Sound Analysis Pro (SAP) 27.  Motifs were compared 
for accuracy, % sequential, and % similarity.  
 
    
3.2.5 Histology, western blot, and HPLC analysis   
All animals were deeply anesthetized with an overdose of Ketamine/Xylazine and 
perfused through the heart with phosphate buffered saline (PBS), followed by 4% 
paraformaldehyde (PFA) in PBS, pH 7 after reaching 120 PHD, with the exception of birds 
used for western blot and HPLC purposes who were perfused 24 h after the final infusion. 
Brains were removed from the skull and post-fixed in 4% PFA, dehydrated through an 
alcohol gradient, imbedded using ImmunoBed (Polysciences, Inc.) and sectioned at 5 µm 
in the sagittal plane. Slice sampling was done in a systematic-random manner.  
Confirmation of injection site was done using widefield fluorescence on a microscope 
(Olympus IX73).   
Tissue was homogenized and proteoglycans extracted using a NP-40 buffer (Fisher 
Scientific) following recommended procedure.  The extract was transferred to a clean tube 
and then loaded three times on to a DEAE-sepharose column (0.25 ml) that had been pre-
equilibrated with 10 column volumes of wash buffer (20 mM NaOAc buffer, pH 6.0, 
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containing 0.1 M NaCl).  The column was then washed with 20 column volumes of wash 
buffer.  Elution of the bound proteoglycans from the column was accomplished using 6 
column volumes of elution buffer (20 mM NaOAc buffer, pH 6.0, containing 1 M NaCl).  
The elution was then filter-desalted using a spin filtration unit MWCO 3000 (Amicon).  
After desalting, sample was used based on the xyloside treated.  Samples from birds treated 
with compound 1 were diluted to 100 µl and a BCA was run to assess protein content using 
Pierce BCA Protein Assay kit (Thermo Scientific).  Based on the outcome of the BSA, 
equal amounts of protein from all samples were loaded and run on a polyacrylamide 4-15% 
gel (Biorad) at 200V for 40 min.  The proteins were then transferred to a nitrocellulose 
membrane at 25V for 45 min.  The membrane was then blocked in 1% evaporated milk 
(Carnation) in TBST buffer and probed with CS56 antibody (1:1000 dilution) overnight at 
4ºC, shaking.  The secondary used was goat anti-mouse IgM-HRP (Fisher Scientific).  The 
membrane was analyzed using the Chemi-doc system (Biorad). 
Samples from tissue treated with compound 2 were incubated overnight with 
streptavidin-AF488 (Fisher Scientific) at room temperature.  After incubation, half the 
mixture was digested with ChABC (Sigma Aldrich) overnight.  Both the undigested and 
digested samples were assessed for a shift in their migration time as compared to only 
streptavidin-AF 488 on a size exclusion column using HPLC.  Two G3000SWXL (7.8 mm 
x 30 cm, 5 µm) size exclusion columns were connected in tandem and the eluted GAG 
chains were loaded onto the columns.  These chains were eluted over 60 min using a 







3.2.6 Statistical analysis and data presentation 
 All data was analyzed by SAP or 3 independent observers.  Data are presented as 
mean ± SD and were compared with an unpaired, or paired, Student's t-test (two-tailed) 




Compound 1 (Table 3.1) showed a high level of GAG priming in multiple cell types 
and has been shown to be nontoxic in cell culture.  Due to these properties, this was the 
molecule used in this study.  Song comparisons showed significant differences between 
song at all three time-points in control birds, using adult song as a template.  Song at that 
age is expected to be highly stereotyped in both acoustic structure and order of syllables.   
Figure 3.1 shows representations of song in spectrograms that show how frequency 
changes over time.  Bouts from two different birds in each group are shown at 60 PHD and 
110+ PHD.  At 60 PHD, both groups lacked stereotypy in both sequence of syllables 
produced as well as in the syllable fine structure.  At 110+ PHD, control birds showed 
highly stereotyped motifs strung together into bouts.  This is normal song development and 
is expected in the zebra finch17-22.  However, the bouts sung by treated birds lacked the 
syntactical stereotypy of the controls.  Syllable fine structure becomes stereotypic in both 
groups. To compare these measures, multiple motifs were analyzed at each time-point for 
all subjects.  First song within the groups was compared at each time-point to the song at 
110+ PHD.  The song at 110+ PHD should be the mature, crystallized song of the bird.  
This comparison would allow the mapping of the developmental trajectory as it approaches 
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crystallized song.  Figure 3.2A-C shows a comparison of these measures.  As expected, 
significant differences (p<0.05) were seen in the sequential and similarity scores as the bird 
developed.  Accuracy scores, which accounted for syllable fine structure, did not show as 
dramatic an improvement, but there was an overall increase between the earliest and latest 
time-points.   
In the treated groups (Figure 3.2A-C), the two areas that showed the most 
improvement in the control birds, similarity and sequential, showed no changes between 
any time points measured.  Accuracy scores showed the same overall increase between the 
earliest and latest time-point.   These data suggest that the infusion of xyloside had a 
marked effect on normal song development, specifically influencing the ordering of 
syllables into stereotypic patterns.  To be sure that one group was not starting with more 
accurate song, data between treatment groups were compared.  Figure 3.2A-C showed that 
both the control and treated groups began at similar scores for all three categories at the 
60-70 PHD time point.   
As time progressed it become clear that the control group was moving toward 
mature song while the treated birds’ scores remained relatively plateaued.  Again, the two 
measures that showed the largest disparity between the groups were similarity and 
sequential scores.  These measures were significantly different (p>0.005) at the 80-90 PHD 
measurements and remained that way (p>0.05) at the latest recording dates.  Accuracy 
scores were not significantly different and increased over time in almost a linear fashion.   
Next motifs within time-points were compared (Figure 3.2D-F).  This allowed an 
assessment of how stable or stereotyped the motifs were within a measured time frame.  
These data were used to compare between groups and show when song development 
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among the two groups diverged.  
In all three categories, both groups were relatively equal at 60-70 PHD.  The motif 
at 60-70 PHD compared to others from the same time-frame would show the two groups 
began as equal, not only in comparison to the bird’s adult song, but also when comparing 
the juvenile song to itself.  Song at this time point was expected to be variable in acoustic 
structure and syllable sequence.  Between groups at 80-90 PHD, it was shown that the 
motifs at 80-90 PHD were not that different; however, the trend showed the control groups 
beginning to rise in both sequential and similarity.  Additionally, the standard deviation for 
the control groups was becoming smaller.  Treated birds did not show this improvement.  
By 110+ PHD, there is a clear difference between the control and treated groups in 
similarity and sequential scores as well as their standard deviations.  This indicated that 
while the control groups were improving over time toward their mature song, but when 
comparing between groups within time-points, the songs only showed clear differences at 
110+ PHD.  
  With song development clearly altered by xyloside infusion, the question arose as 
to how the xyloside is changing GAG biosynthesis in the zebra finch brain and how these 
changes may be responsible for the behavioral changes measured.  Xylosides have two 
major functions:  priming and serving as a decoy.   
To prime, xylosides enter the Golgi and the enzymatic machinery extends and 
modifies a carbohydrate chain on the xylose.  The primed GAG chain is then sent out of 
the cell and into the ECM28-30.  The expulsion of these chains into the ECM may allow 
them to function in a manner similar to endogenous PGs such as binding ligands and/or 
receptors, providing axonal guidance cues, or stabilizing synapses.  Additionally, xylosides 
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are known to serve as “decoy” molecules for these enzymes28,29.  In this instance, the 
function of priming occupies enzymes that would normally be functioning on endogenous 
proteins to make proteoglycans.  This results in a loss of protein-bound GAGs, but not a 
loss of the core protein itself.  This decrease in endogenous PGs may affect gradient 
formation of morphogens/ligands, axonal pathfinding, neurite outgrowth and support, as 
well as overall ECM structure. 
First the possible decoy action of the xyloside was examined.  Figure 3.3 showed 
that in the xyloside treated samples, there was a distinct lack of chondroitin sulfate as 
compared to vehicle treated samples as seen by western blot.  The ladder shows that both 
transfer and antibody probing procedures were followed correctly.  As the antibody used 
is against CS specifically, this is responsible for the larger band size.  The lanes containing 
wash for each condition show that our purification was effective.  In comparing the purified 
proteoglycans from both groups, xyloside treated birds show a reduction in CS as compared 
to vehicle treated controls.  This indicated that the xyloside was serving as a decoy and 
prevented the synthesis of endogenous PGs.  However, analysis of the GAG chains by mass 
spectrometry did not indicate a loss of overall GAG.  This was an indication of priming.  
To examine priming, it was necessary to use a molecule that would allow us to capture 
only the GAGs that were attached to the xyloside.  To accomplish this, a biotinylated click-
xyloside, or a xylose with a biotin molecule as the aglycone (compound 2) was used.  
Figure 3.4B shows that compound 2 primed GAG chains in the juvenile brain  







The data presented in this study offer a new look at developing song and the role 
of GAGs in the nervous system.  Tightly regulated GAG biosynthesis is critical for the 
developing nervous system,2,3,5-10 and modulation of biosynthesis can lead to permanent 
changes in a learned behavior.  The data show that induced modulation of CS, even 
relatively early in a critical period, can have lasting effects on neural development.  Using 
song as an assay allows the examination of the role of CS in establishing a motor program 
for a complex behavior that requires sophisticated sensory-motor integration.   
The time course of song development and ontogeny of vocal features following 
GAG modulation suggests a specific rather than global effect.  The improved accuracy 
scores indicate that the acoustic structure becomes stereotyped as seen in both the control 
and treatment group.  However, while acoustic structure shows less variation in the treated 
birds, this increase in scores does not include an improvement in stabilizing frequency 
trajectories of modulated syllables.  The retained wavy nature of frequency trajectories is 
indicative of plastic song in the zebra finch31 and is not seen in the control group after or 
near crystallization.  Because syringeal muscles play an important role in frequency 
control32 the failure to sing smooth frequency trajectories indicates an unstable neural 
control strategy.  
In addition, the main difference between treatment and control birds is a lack of 
progress in developing stereotypy of song syllable sequence in the former, whereas a 
typical trajectory of increased stereotypy is seen in the control birds19,20-22.  Control of 
syllable sequence is thought to arise from combined input from HVC and the cortico-
thalamic anterior forebrain pathway into RA. Interestingly, disruption of acoustic 
87 
 
feedback causes a loss of stereotypy in adult zebra finches33-35, and this effect is mediated 
through anterior forebrain pathway36.  The lack of stereotypy in song sequence after 
manipulation of the CS dynamics in RA thus suggests that changes in RA circuitry that 
are associated with perineuronal net formation account for the lack of stereotypy in song 
sequence.  
The respective roles of HVC and RA have been inferred from single cell 
recordings in each nucleus during song production37. The model postulates a major role 
of HVC in controlling all major aspects of temporal structure, including syllable 
sequence37,38. RA was assigned a less significant role in the control of temporal aspects of 
song. This view seems consistent with effects on song from electrical stimulation of each 
nucleus.  Electrical stimulation in HVC of singing birds caused abortion of song motifs, 
while stimulation of RA resulted in changes in the acoustic structure of individual 
syllables38.  However, this model has been challenged by an alternative model that 
postulates a more distributed control of temporal aspects of song39.  Our data do not 
directly address this question, but indirectly support the distributed control hypothesis.  
The fact that song syllable sequence ontogeny depends on the internal circuitry of RA is 
in apparent contradiction with the stimulation results. However, if one considers that 
electrical stimulation affects the downstream circuitry of the stimulated area, rather than 
the fine processing in the stimulated nucleus, then the results are not contradictory.   
Our data also strongly suggest that the developmental trajectories of stereotyped 
acoustic structure and stereotypy in syllable sequence are not interdependent.   Because 
the acoustic structure showed increased stereotypy over developmental time, while 
syllables retained less controlled frequency trajectories in the treated birds, it is likely that 
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these two aspects of vocal ontogeny are not tightly linked. The change in RA circuitry 
following CS manipulation must have prevented the generation of a smooth neural signal 
for frequency control in the hypoglossal nucleus, but allowed this frequency control 
mechanism to become stereotyped over the course of vocal ontogeny.   
These results indicate that the role of CS in RA during song development is 
complex.  We have shown that xylosides can have two distinct roles in vivo, serving as 
either a decoy which disrupts endogenous GAG biosynthesis28,29 or as a primer on which 
GAG is formed and released into the ECM27.  One possible mechanism of xyloside action 
is that it reduces endogenous GAGs.  Reduction of CS may lead to changes in synapse 
formation and maturation40,41.  These alterations may lead to continued plasticity through 
adulthood or deficits in neural wiring which may be necessary for vocal ontogeny.  
However, unlike juvenile zebra finches, treated birds did not incorporate new syllables 
into their songs after treatment, which argues against the idea that the treatment 
prolonged plasticity beyond the normal age for song crystallization. 
The more likely mechanism is that the priming effect of xylosides may provide 
the nucleus with a premature PNN like structure, which may lead to the change in 
behavior.  Infusion occured between 55 and 65 PHD, but primed GAG and xyloside 
remain in the tissue and may still be priming for several days after infusion.  These 
primed GAGs may function in a fashion similar to a PNN and support synapses and 
reduce plasticity.  This reduction of plasticity could be manifested in a reduction in the 
normal pruning of synapses during development.  Eventually, these primed GAGs would 
be cleared or disposed of, allowing normal development to continue.  However, by this 
time, the developmental window for vocal ontogeny may be closing naturally as the 
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critical period comes to an end.  This would explain the slight improvement seen between 
70-80 PHD and 110+ PHD in sequential scores in the treatment groups.  Improvement 
towards stereotypy is stopped by normal crystallization and adult song consists of 
somewhat immature syntax.  
Finally, it is possible that both the decoy and priming aspects of xyloside 
treatment are required for the developmental deficit to occur.  In this scenario, the loss of 
endogenous GAG chains through the decoy effect and the primed GAG chains present in 
the ECM network serve to amplify inhibition of neural plasticity in RA.  This combined 
effect would make it difficult to complete normal developmental changes in the nucleus.  
After some time, the effect may wear off, which would explain the slight improvement in 
similarity and sequential scores. However, normal crystallization occurred before the bird 
could completely recover. 
Understanding whether the results seen are due to a single mechanism or require 
both priming and decoy function will be vital to a better understanding of the role of 
GAGs and their biosynthesis in complex neural systems.  Future studies will examine 
both the decoy and priming effects of xylosides and allow us to determine which is 


















































































































































































































































































Figure 3.2  Analysis of motifs between time-points using 110+ PHD song as template 
(A-C) and comparison of motifs within time-points (D-F) for both xyloside treated and 
vehicle treated birds.  The three measures that were assessed in both instances were 
accuracy (A, D), the sequence of the motif (B,E) and the overall similarity (C,F) of the 
motifs.  Significant differences are marked by * or letters (a, b, c).  *,a  indicates p<0.05,  
**,b indicates p<0.005, and ***,c indicates p<0.001.  Letters were used to indicate 













Figure 3.3  Confirmation of decoy and priming effect of xylosides in juvenile zebra 
finch. (A) Coomassie and western blot using CS56, a CS antibody, of purified 
proteoglycans from treated (xyloside) and sham (vehicle) tissue from zebra finch brain 
after normal treatment schedule.  Western blot analysis shows that CS bound to 
protein is reduced after xyloside treatment.  As the antibody is against CS, the area 
stained is wider as compared to a protein.  (B)  Priming using a biotinylated xyloside 
shows primed GAGs by the shift in fluorescence, which is abolished after ChABC 
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CHAPTER 4  
DEGRADATION OF HEPARAN SULFATE IN SYRINGEAL  
 
MUSCLE LEADS TO CHANGES IN CRYSTALLIZED  
 






Human speech and birdsong are complex behaviors that require central neural 
control in conjunction with precisely coordinated muscle output to control respiration, 
vocal parameters, and upper vocal tract movements1-4.  Birdsong is produced by the avian 
vocal organ, the syrinx, through airflow that is generated by respiratory control.  In birds, 
both expiration and inspiration are active processes and require concerted muscle 
activity5,6.   
  Located at the junction of the primary bronchi and the trachea, the syrinx consists 
of two ipsilaterally controlled sound generators.  These sound generating tissue masses, 
the labia, are attached to modified cartilage rings and can act as airflow control valves as 
well as a sound source.  The position of the labia in the bronchial lumen as well as their 
vibratory behavior is controlled by at least six pairs of muscles (Figure 4.1)6-8.   
 In the zebra finch, variation in spiking patterns in neurons is correlated with 
variation in temporal song characteristics9,10.  This suggests temporal precision in the 
CNS is expressed at the behavioral level in song.  This high precision in neural motor 
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commands can be translated into rapid movements of the vocal organ and thus into 
acoustic features.  Syringeal muscles contain superfast contractile kinetics allowing for 
unique acoustic modulations.  These kinetics allow for rapid modulation of syringeal 
airflow and sound amplitude12,13.  In the zebra finch, the fiber type composition and speed 
of syringeal muscles are sexually dimorphic.  Male muscles contain a higher percentage 
of superfast fibers (75-85% in males vs 50-60% in females14) and show faster contraction 
kinetics14.  Emg recordings1,2,7,16 and denervation studies15,17,18 indicate that syringeal 
muscles play important roles in song production and control of acoustic parameters.  For 
example, in canaries (Serinus canaria), active control of the syringeal valve is required for 
phonation19.  Syringeal muscles are also critical for control of fundamental frequency.  
The frequency of song syllables drops drastically after denervation in all investigated 
oscine species15,17. 
 However, the specific contributions of muscles to acoustic features are still largely 
unknown and therefore, how the presence of superfast fibers affects acoustic 
characteristics of song, such as frequency and amplitude, remains unknown.  While the 
sexual dimorphism in syringeal muscle morphology and kinetics15 suggests that these 
muscles may have evolved for vocal control, there is not experimental data to substantiate 
this hypothesis.  To address the question of muscle contribution to song characteristics, 
the use of heparitinase enzymes to alter the ECM of the syringeal muscle was employed.    
Skeletal muscles are known to contain heparan sulfate.  HS is primarily found at 
the NMJ and are involved with its formation during development, aggregation of AChR, 
and the tethering of AChE20-24.  This study provides the first evidence that superfast 
muscle activity is involved in a wide array of song features such as amplitude, 
high-frequency syllables, and frequency modulation, that degradation of HS in these 
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superfast muscles alters their kinetic activity, and that altering this activity can lead to 




4.2 Methods and materials 
4.2.1 Animals   
Adult male zebra finches were used in this study.  Birds were bred in a flight 
aviary at the University of Utah.  Birds were housed in the aviary until experimental 
testing.  During testing, birds were housed in 32 x 23 x 30-cm wire cages and kept on a 
13:11-h light:dark cycle.   
 
 
4.2.2 Air sac pressure measurements and recordings   
Males were removed from the aviary and place into individual cages and isolated in 
acoustic recording chambers.  Several bouts of control song were recorded after which an 
elastic belt was placed around the thorax with a leash connected to the belt using a Velcro 
tab.  The leash was put through the top of the cage and connected to a counterbalanced 
tether arm to allow free movement around the cage.  After the bird was accustomed to the 
tether, as indicated by singing, surgery was performed.  Birds were deprived of food and 
water for 1 h prior to surgery and then anesthetized using isofluorane.  A small hole was 
made in the abdominal wall to insert a flexible cannula into a thoracic air sac.  The cannula 
was sutured to the rib cage and the insertion site sealed with tissue adhesive (VetBond) to 
prevent air leakage.  The other end of the tube was connected to a pressure transducer 
(Fujikura FPM-02PG) mounted on the bird as a backpack connected to the Velcro tab on 
the belt.  Birds were allowed to recover until several bouts of control song with 
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simultaneous air sac pressure were recorded.  Song was recorded with an omni-directional 
microphone and amplified (Digital Preamp system II, Applied Research Technology).  
Air sac pressure was simultaneously recorded on a separate channel using amplified output 
(Hector Engineering) from the pressure transducer.  Both channels were recorded with a 
Data Translation AD-board at 44.1 kHz sampling rate using Avisoft Recorder software.  
After sufficient control song was recorded, birds received injections of enzyme. 
 
 
4.2.3 Injection into syringeal muscles   
Several groups of birds received bilateral injections of heparitinase enzymes or 
vehicle in the syrinx.  Heparitinase enzymes were expressed and purified as previously 
described.  Vehicle consists of the same buffer the enzymes are stored in to serve as a 
control. This includes birds for the examination of song alone (n=6), those for examining 
song and pressure patterns (n=5), and birds in which the effect of enzyme treatment on 
syringeal muscle function was studied (n=8; see below).  All procedures were as follows, 
regardless of experimental group.  Birds were deprived of food for 1 h prior to surgical 
procedure and then anesthetized using isofluorane.  The thoracic cavity was opened and 
10 µl of a mixture of heparianse enzymes or vehicle were injected bilaterally into the 
ventral muscles of the syrinx.  The membrane of the interclavicular air sac was sealed with 
tissue adhesive and the overlying skin was sutured closed.  Birds were allowed to recover 
from anesthesia and then returned to their recording chambers.  Song, and air sac pressure 
in the subset, was recorded as described previously.  Birds designated for the investigation 
of the treatment on song features (song alone as well as song and air sac pressure) were 
recorded for up to fourteen days post injection.  For birds the effect of the infusion on 
muscle kinetics was tested through measurement of the stimulation threshold and 
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assessment of air flow modulation at varying frequencies.  Additionally, their song was 
recorded for up to 24 h post injection at which time the syringeal muscle kinetics were 
assessed.  
 
4.2.4 Recording of muscle kinetics   
To assess how enzyme treatment affects muscle contraction kinetics, the effect of 
oscillatory in situ muscle contractions on airflow was monitored. To do so, a custom-built 
flow probe was inserted into the trachea. This flow sensor was constructed with a miniature 
thermistor (Thermometrics BB05JA202), which was connected to a feedback circuit 
(Hector Engineering) that heated the thermistor to approximately 60 °C via output current. 
This feedback circuit provides sensitive detection of airflow in the trachea, as the 
convective cooling of the flow induces adjustments in the heating current and thus provides 
a proportional voltage signal.  Syringeal muscles were stimulated directly with a pair of 
silver wires (AM-Systems) inserted into the ventral tracheobronchial muscle.  To detect 
the abductive activity of this muscle, the respiratory system of the bird was perfused 
through a cannula in the posterior thoracic air sac. This procedure turned off the bird’s 
respiratory drive and allowed us to test modulation of a constant air stream by the muscle 
without interference from fluctuations in airflow associated with the natural breathing 
rhythm. Stimulation pulses were delivered in trains and between trains the muscle was 
allowed to recover for at least 2 min.  Pulse frequency was first ramped up in discrete steps 
(10, 20, 25, 30, 40, 50 Hz) and then ramped down (50, 40, 30, 25, 20, 10 Hz).  Airflow and 







4.2.5 Song and air sac pressure analyses   
At least 15 motifs from each bird were selected randomly from the recordings.  
Within these selected motifs frequency modulation, fundamental frequency, sound onset 
pressure, and amplitude were analyzed using Praat software (www.praat.org)25.  
Frequency modulation was examined (n = 6) by calculating the change in frequency over 
time using the fundamental frequency from the highest point to the lowest point in a sweep.  
Amplitude was calculated by averaging intensity over the entire motif (at least 15 motifs 
analyzed for 4 birds in each treatment group).  Pressure at the onset of phonation was 
measured by high-pass filtering the pressure pattern for each bird to reveal the syringeal 
oscillations and accurate measurement of the fundamental.  The pressure level at the onset 
of vibration was measured.  This was considered the start of phonation and a power 
spectra of this time showed the fundamental frequency (n = 4).  Statistics were calculated 
using a paired or unpaired Student t-test where appropriate. 
 
4.3 Results 
After injection, a timeline for the effectiveness of the treatment was established.  
Birds were allowed to recover and song was recorded for up to two weeks post injection.  
Data analysis consists of primarily three time-points:  prior to injection, 24 h post 
injection, and 7 d post injection.  These time-points were chosen due to the fact that data 
analysis shows the greatest differences in song attributes at 24 h post injection with many 
of these resolving by 7 d post injection and others becoming more apparent at this time.  
Using this timeframe, song with pressure components were analyzed.  Muscle activity 
was examined 24 h post injection. 
Examples of pressure pattern, sound traces, spectrograms, and intensity (or 
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amplitude) over a motif can be seen for two enzyme treated birds in Figure 4.2.  One of the 
most obvious changes at 24 h post injection was to the sound amplitude of song.  Vehicle 
treatment resulted in a slight but significant decrease in sound amplitude (~2dB).  
Treatment with enzyme resulted in a consistent decrease in mean song amplitude of 4-6  
dB at 24 h post injection relative to that before injection (Figure 4.3A).  Seven days after 
the injection, sound amplitude had returned to pre-injection levels.  In comparison to the 
overall effect on song amplitude, the amplitude of high frequency notes even further 
reduced (Figure 4.2, shown at the asterisk; Figure 4.4).  These notes between 3.5-7 kHz 
were either significantly reduced by >5 dB or were not present at all.  This effect was 
temporary as by 7 d post injection the notes had returned.   
Loss of high frequency syllables could not be attributed to a change in airflow as 
inferred from the largely intact air sac pressure patterns (Figure 4.4). Pressure patterns in 
adult zebra finch song are as stereotyped as the syllables sung.  Pressure is the result of the 
respiratory effort and syringeal resistance.  Syringeal muscles through their gating activity 
can affect air sac pressure.  Whereas the overall pressure amplitude remained unaffected 
by the injection, relative amplitude of pressure peaks did change after injection (e.g., 
Figure 4.4)  Enzyme injection also altered the phonation onset pressure (Figure 4.5A).  In 
all subjects, the phonation onset pressure for most syllables was increased post injection 
(average increase was 56.1%).  This increase does not appear to be frequency dependent 
(Figure 4.5B) 
With the exception of the high frequency syllables, no substantial change in 
fundamental frequency was observed after treatment.  However, frequency modulation 
(FM) was affected by the treatment.  FM-rate was found to decrease at 24 h post injection, 
but only in specific syllables (Figure 4.6).  From the limited sample it appears that this 
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change was dependent upon the higher FM rate and not on the fundamental frequency.  
Changes to amplitude and frequency features of song were not the only observed 
outcomes of enzyme treatment.  Syntax of motifs within bouts began to show unusual 
patterns several days after treatment (Figure 4.7).  These changes included the presence of 
syllables and associated pressure pulses that were not present in the motifs before injection 
of enzyme, an unusual number of introductory notes inserted between the motifs of a song 
bout, and even increasing repetition of syllables at the end of motifs.  These changes 
occurred several days after enzyme injection and persisted beyond the 7 d post injection 
mark.  
In examining changes to the actual muscle, neuromuscular transmission was first 
examined.  Stimulation of the tracheosyringeal nerve produced muscle twitches, 
indicating that neural transmission to the muscle remained intact. Using direct stimulation 
of the muscles revealed a change in the stimulation threshold current with enzyme 
treatment.  Whereas muscle contractions could be elicited with <0.5 mA stimulation 
current in vehicle injected birds, in enzyme injected birds, the threshold was between 0.5-1 
mA. 
The frequency response of muscles was significantly lower after enzyme, as tested 
via muscle-mediated airflow modulation.  Reduced ability to modulate airflow occurred 
at lower stimulation frequencies in enzyme treated birds compared to vehicle injected birds    
(Figure 4.8).  Stimulation of enzymatically treated muscle no longer caused visible 









Syringeal muscles play a role in controlling airflow and the tension of the vibrating 
labia1-9,11-18. They consist of a high percentage of superfast fibers with extremely fast 
contraction kinetics12,14. Eliminating contributions from muscles through denervation 
results in drastic changes to fundamental frequency and some temporal characteristics15-18. 
Aside from this demonstration that muscle activity is required for normal song production, 
it is completely unknown to what degree the kinetics of syringeal muscles affect acoustic 
features. These results provide the first data to answer this question. 
Syringeal muscles are involved in several aspects of song production and, 
interestingly, play a role in maintenance of stereotyped song1-9,11-13,15-19.  Treatment of 
these muscles with HS degrading enzyme caused a change in muscle kinetics, increasing 
the stimulation threshold and lowering the frequency at which tetanus is observed.  The 
change in kinetics indicates that HS in the ECM of syringeal muscles plays a role in 
maintaining proper muscle response and affects the contractile properties of the muscle.  
Removal of HS leads to changes in the superfast characteristics of syringeal muscles, 
which allowed us to study the importance of muscle function for stereotyped song 
production. 
Because syringeal muscles play a major role in the control of fundamental 
frequency15, changes in frequency after HS manipulation could be expected. However, 
after enzymatic treatment of syringeal muscles, a universal change in fundamental 
frequency did not occur.  In many syllables, the fundamental frequency remained 
unchanged at 24 h post enzyme injection, which is in contrast to a global change after 
denervation15-18.  The manipulation did affect high-frequency syllables, such as the more 
tonal notes or harmonic-stack syllables with fundamental frequency over 2 kHz. However, 
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the main effect was a reduction in sound amplitude or complete loss of high-frequency 
syllables and not a decrease in frequency.  Furthermore, significant changes in frequency 
modulation also occurred for high-frequency components.  This loss is not attributable to 
a reduction in driving pressure, which did not significantly change after infusion of 
enzyme.   The reduction in sound amplitude of tonal syllables, rather than a lowering of 
the fundamental frequency, is surprising and must be caused by the altered kinetics of the 
syringeal muscle.       
The loss of high-frequency syllables may indicate an important, more general 
function of syringeal muscles that has not been appreciated until now. The overall 
reduction in sound amplitude (4-6 dB) suggests that muscle activity controls sound 
amplitude in a general way. This change is not explained by a surgery effect, as control 
birds showed at most a 1-2 dB reduction.  Although amplitude modulation is controlled by 
syringeal muscles that gate airflow1,2,4,  the general influence on sound amplitude seen 
here implies a different mechanism.   Perhaps, muscle activity positions the syrinx and 
the labia in a way that allows optimal transfer of aerodynamic energy into sound energy. 
The manipulation with enzyme may have disrupted this positioning movement. 
This interpretation is further supported by the fact that phonation threshold pressure 
was affected by the manipulation. The pressure at which phonation began at the onset of 
syllables was increased by at least 10% in 76% of all syllables.  This is likely caused by 
reduced ability for proper positioning of the labia in the airstream or an overall reduction in 
the configuration and tension of syringeal structures. This result is particularly interesting 
because phonation threshold pressure did not change between the in situ intact and 
denervated syrinx as well as the excised syrinx that were artificially phonated24. It 
therefore implies that syringeal muscles actively increase vocal efficiency and that this 
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mechanism is dependent on contraction kinetics or excitability of the muscles.   
Reduction of amplitude and the loss of higher frequencies are reversible alterations 
to song that occur swiftly after enzymatic treatment and have a time-course of about a week 
after treatment before returning to normal levels.  Other changes in the stereotyped adult 
song appear later and persist well beyond the one-week timeframe.  In birds who received 
injections of heparitinase enzymes, novel syllables, or atypical repetition of syllables was 
seen as early as 2 d post injection and persisted beyond 7 d post injection.  Similar changes 
to song in adult zebra finches were reported following either manipulations of brain 
nuclei27-29 manipulations of acoustic feedback (deafening, noise distortion, syringeal 
denervation14-18,30-32) or muting33, but the time course is typically much slower. Enzyme 
injection to the syrinx resulted in changes to song which produced altered auditory 
feedback and must also have altered somatosensory and proprioceptive feedback.  The 
more rapid time course for song changes after this manipulation suggests that a more subtle 
disruption of feedback information, auditory or somatosensory, produces a more rapid 
response in song output, perhaps through sensitive compensatory mechanisms. The fact 
that these changes persist beyond 7 d implies that once the feedback loop induced 
compensation occurs, the process is not easily reversed or halted.  Novel patterns are then 
incorporated into and maintained in adult song, even after feedback presumably returns to 
the original state as acoustic changes are reversed around 7 d after infusion of enzyme.   
This study provides a novel method for examining the specific roles of syringeal 
muscles in song production as well as the sensitivity and reactivity of the feedback loop 
that maintains adult zebra finch song.  The kinetics of syringeal muscles can be altered by 
injection of heparitinase enzymes, which leads to reversible changes in amplitude, 
frequency modulations, and the production of high frequencies in stereotyped song.  
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These changes may lead to disruption of the normal feedback system used to maintain 
stereotyped adult song, which could result in new or repeating syllables.  These long-term 
changes emphasize that temporary modulation may have dramatic effects on a stereotyped 
behavior and that the kinetics of the syringeal muscles are important for the production and 
maintenance of song.  This study provides a starting point for a better understanding of the 
roles of syringeal muscles in producing specific song features and for examining how 
GAGs are involved with superfast muscle function.  Additionally, it provides an 
interesting tool for examining the feedback system of adult zebra finch song and how 







Figure 4.1.  The schematic of a syrinx, the avian vocal organ that shows the six pairs 































































































































































































































































































































Figure 4.3 Comparison of song amplitude (in dB) before and 24 h after heparitinase 
treatment. (A) Shows the % of pre-injection amplitude of song at 24 h and 7 d for enzyme  
treated and 24 h for vehicle treated birds. (B) The difference in dB of song amplitude 24 h 











































































































































































































































































































































































































































Figure 4.5  Pressure at phonation onset is changed 24 h after enzyme treatment, with 22 of 
the 26 syllables examined showing at least a 5% increase in pressure (A).  When comparing 
the change in pressure as a function of frequency, no obvious correlation is seen between 




Figure 4.6.  Changes in frequency modulation are measured in 6 specific syllables from 4 
different enzyme treated birds and significant changes are shown to be syllable dependent.  
In several syllables, there is a significant change in FM (*p<0.05; **p<0.005), but others 
show no change.  This may be due to the highest frequency in the sweep.  If it is above a 
certain frequency, it may be lost in a similar fashion to the tonal syllables.  The start and 













































































































































































































































































































Figure 4.8  The percent modulation of airflow by syringeal muscle during stimulation of 
vehicle and enzyme treatment 24 h after injection as compared to that at 10 Hz.  Enzyme 
treated muscle shows an inability to modulate airflow at lower frequencies of stimulation 
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 Song learning and production is a complex process that requires intricate 
coordination of multiple neuromuscular systems1-10.  The zebra finch model system for 
vocal learning closely mirrors vocal learning in humans11-13.  This dissertation examines 
the role of GAGs in both the neural and muscle control of vocalizations.  GAGs are present 
and play critical roles in the brain14-18 as well as in skeletal muscle19-21; however, the exact 
mechanism of GAG function is unclear in most cases.  In order to expand our understanding 
of these carbohydrate molecules, it is necessary to first modify and create tools and 
methods for the study of GAGs.  Chapter 2 shows the production, purification, and 
characterization of GAG degrading enzymes, sulfated polymers and oligosaccharides, and 
xylosides. Utilizing these tools will allow for a better understanding of GAGs in biological 
systems such as vocal learning; however, it is imperative to continue to improve and create 
methods to understand and manipulate GAGs and their biosynthetic pathways. 
 To prove the efficacy of the most commonly used of these tools, degradation of 
GAG by enzymes, heparitinase enzymes were infused into the posterior forebrain nucleus 
HVC, which is known to be involved in song production.  Infusion of these enzymes into 
adult male zebra finches resulted in changes to both acoustic syllable structure, timing 
between syllables, and (in some cases) overall syntax.  As adult zebra finch song is highly 
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stereotyped, any of these alterations is notable.  These preliminary data showed that the 
GAG degradation enzymes can be used effectively in the zebra finch and that GAGs appear 
to have an important role in vocalizations. 
The research presented in Chapters 3 and 4 shows two examples of how these 
biochemical tools can be used to examine roles of GAGs in vocal ontogeny and production 
in the zebra finch.  Because the involvement of GAGs in vocal behavior is relatively 
unexplored, this research provides an interesting backdrop for exploration into speech 
learning and disorders.  Many speech and communication disorders have no known cause 
and show no obvious anatomical defect.  This leads to the possibility that perhaps it is small 
changes, or specific changes, during development that may lead to these disorders.   
In Chapter 3, Xylosides were used to alter CS biosynthesis early in development, 
which led to distinct changes in vocal ontogeny.  Treated birds showed little if any 
improvement in song syntax and similarity, effectively singing juvenile song at adult ages.  
This suggests that the biosynthesis of GAGs, specifically CS, is critical for proper vocal 
development in the zebra finch.  CS is known to play a role in plasticity14-17, so 
manipulation through xyloside offers a unique method for understanding CS in plasticity.  
As xylosides can serve as both an inhibitor and a primer22-24, it is important for future 
studies to thoroughly examine if only one aspect is required for the changes in vocal 
ontogeny or if it is necessary for both inhibition and priming to occur.  Additionally, the 
concept of GAG chain valency for biological action is becoming increasingly important.  
The xyloside employed in this work is monomeric, having only one xylose residue.  As 
seen in Chapter 2, the production and analysis of multimeric xylosides is ongoing.  
Multimeric xylosides, or molecules with two or more xylose residues, can prime multiple 
GAG chains per molecule.  Using these multimeric xylosides may result in primed 
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multimeric GAGs that can react in a fashion that mimics endogenous proteoglycans25.  
Future studies in the zebra finch can explore whether infusion of xylosides, monomeric or 
multimeric, into song specific nuclei, including but not limited to RA, may alter vocal 
ontogeny differently.  Understanding the differences that may occur due to valency, 
modulation of biosynthesis, or altering the GAG profile in each song nucleus may provide 
a clearer picture for the timeline of neural changes that underlie critical periods of vocal 
ontogeny and how manipulation may be possible.  This goal of understanding vocal critical 
periods would lend itself to a better understanding of vocal ongoteny in general and 
possible targets that may allow for delayed closure of the critical periods in both vocal and 
other systems.  Delaying the critical period for vocal development in humans would 
provide more successful results for those who receive a cochlear-implant later in life. 
Chapter 4 shows that HS degradation in syringeal muscles can impact muscle 
kinetics and alter stereotyped song in adult zebra finches. The data suggest that syringeal 
muscles play a role in several aspects of song, including: amplitude, production of high 
frequencies, frequency modulation, and pressure at phonation onset.  Additionally, 
disrupting the muscle output may disrupt song feedback, through auditory or 
proprioceptive means, into the neural control system and result in rapid and long-lasting 
alterations to crystallized song.  These data are the first to show the role of syringeal muscle 
kinetics in acoustic structure.  The addition of novel, or repeating, syllables provides an 
interesting look into the song feedback system and an opportunity for further study.  Novel, 
or repeating, syllables can appear as early as 48 h after infusion, suggesting a rapid response 
to the temporary acoustic effects.  It would be interesting to explore the function of this 
feedback loop and if these alterations to stereotyped song are due to the change in auditory 
feedback (lower song amplitude, changes in frequency) or whether proprioceptive 
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mechanisms are involved.  Since research into disruption of auditory feedback show that 
changes in song are mediated by the anterior forebrain pathway26-28, similar research could 
be used to explore if similar neural mediation is used after changes in syringeal muscle 
kinetics.  While these studies show only the initial steps into understanding how GAGs are 
involved in complex sensorimotor behaviors such as song learning and production, they 
emphasize the importance of looking into nontemplated molecules as modulators of 
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